WO2009125483A1 - Hard capsule - Google Patents

Hard capsule Download PDF

Info

Publication number
WO2009125483A1
WO2009125483A1 PCT/JP2008/057084 JP2008057084W WO2009125483A1 WO 2009125483 A1 WO2009125483 A1 WO 2009125483A1 JP 2008057084 W JP2008057084 W JP 2008057084W WO 2009125483 A1 WO2009125483 A1 WO 2009125483A1
Authority
WO
WIPO (PCT)
Prior art keywords
capsule
film
hard capsule
polyvinyl alcohol
pva
Prior art date
Application number
PCT/JP2008/057084
Other languages
French (fr)
Japanese (ja)
Inventor
信治 栃尾
光一 吉中
忠省 峯田
邦夫 西
Original Assignee
クオリカプス株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by クオリカプス株式会社 filed Critical クオリカプス株式会社
Priority to PCT/JP2008/057084 priority Critical patent/WO2009125483A1/en
Priority to JP2010507091A priority patent/JP5289429B2/en
Publication of WO2009125483A1 publication Critical patent/WO2009125483A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use

Definitions

  • This invention relates to the improvement of the hard capsule which uses a polyvinyl alcohol copolymer as a capsule film component. More specifically, the present invention relates to a hard capsule having improved crack resistance and impact resistance by improving the elongation at break of the capsule film (film) of the hard capsule, and a method for preparing the same. Furthermore, the present invention relates to a hard capsule obtained by filling the hard capsule with contents such as pharmaceuticals and foods, and a method for preparing the same.
  • a hard capsule as one of solid preparations such as pharmaceuticals and foods. This is usually filled with a powder, granule, or liquid (oil) pharmaceutical ingredient or food ingredient in a cap-like container, which is usually formed of a gelatin film, and open at one end. And completed.
  • a hard gelatin capsules are widely used because they are easy to formulate and easy to take due to the taste-masking and / or taste-masking action of pharmaceutical ingredients and food ingredients.
  • the gelatin film (coating) used in the hard gelatin capsule has a drawback that its mechanical strength is extremely lowered when the moisture contained therein is reduced.
  • hard gelatin capsules usually contain about 13 to 15% of moisture in the film, but if this is less than 10%, the film becomes less flexible and extremely brittle. For this reason, when filled with contents that require a low moisture environment as storage conditions, such as water-absorbing or water-reactive drugs and foods, the capsule film (film) will be cracked, cracked or chipped. May cause damage.
  • a capsule (Patent Document 1) using a water-soluble cellulose derivative, particularly hydroxypropylmethylcellulose (hereinafter referred to as “HPMC”) as a base material has been proposed.
  • the crack elongation and the impact resistance are enhanced by improving the elongation at break while maintaining a predetermined maximum stress of the capsule film (film). It is an object to provide a hard capsule.
  • the inventors of the present invention have been diligently studying day and night to achieve the above object, and as a film component of the capsule, polyvinyl alcohol copolymer (hereinafter referred to as “PVA copolymer”) and polyvinyl alcohol (hereinafter referred to as “ PVA ”) and a combination of an organic acid such as acetic acid and tartaric acid or a salt thereof, while maintaining the predetermined maximum stress required for hard capsules, the capsule film breaks. It was found that the elongation was improved, and as a result, it was confirmed that it was possible to prepare a hard capsule that was more resistant to breakage and resistant to impact.
  • PVA copolymer polyvinyl alcohol copolymer
  • PVA polyvinyl alcohol
  • the present invention has been completed based on such knowledge and includes the following aspects.
  • Capsule molding pin is dipped in a capsule preparation liquid containing PVA copolymer and PVA, and the capsule preparation liquid attached to the molding pin is gelled and dried, and then molded.
  • Hard capsule (II) A hard capsule comprising the hard capsule described in any one of (I-1) to (I-10) filled with polyethylene glycol or a composition containing polyethylene glycol .
  • Capsule film break elongation improvement method (III) Capsule film break elongation improvement method (III-1) Capsule film break elongation improvement method containing a PVA copolymer, characterized in that a PVA copolymer and PVA are used in combination as film components. how to.
  • the weight ratio of the PVA copolymer to PVA blended in the capsule film is 100: 1 to 1: 100, preferably 99: 1 to 1:99, (III-1) A method for improving the breaking elongation of a capsule film to be described.
  • the weight ratio of the PVA copolymer to PVA blended in the capsule film is 90:10 to 1: 100, preferably 90:10 to 1:99. A method for improving the breaking elongation of a capsule film to be described.
  • the weight ratio of the PVA copolymer to PVA blended in the capsule film is 50:50 to 1: 100, preferably 50:50 to 1:99. A method for improving the breaking elongation of a capsule film to be described.
  • the film component further includes at least one selected from the group consisting of an organic acid and a salt thereof, and is described in any one of (III-1) to (III-4) Method for improving elongation at break of capsule film.
  • the hard capsule of the present invention has almost the same maximum as a capsule film (coating) prepared by using a PVA copolymer without using PVA by using a PVA copolymer and PVA together as a film component. Although it is provided with stress, the elongation at break is improved, and as a result, it is a hard capsule in which cracks and cracks are less likely to occur even under low moisture (improved crack resistance). Improved cracking resistance improves (1) the production of defective products such as cracks and chips during capsule production, and improves production efficiency. (2) Physical properties such as shock and vibration during transport of capsules. There are advantages in that capsule breakage due to mechanical load is reduced, and (3) capsule breakage due to physical load caused by formulation machines such as filling machines and visual inspection machines is reduced.
  • capsules filled with the contents also reduce (i) capsule breakage due to physical loads such as impact and vibration during transportation. (Ii) Extrude PTP-packed capsules with fingers. There is an advantage that the breakage of the capsule due to the physical load at the time of taking out is reduced.
  • the hard capsule of the present invention is a low-molecular-weight PEG, a glycerin fatty acid ester, a medium-chain fatty acid triglyceride, and the like, similar to a hard capsule prepared using a conventional PVA or PVA copolymer (see Patent Documents 2 to 4). Oils and fats can be filled without any inconvenience, and there is no permeation of water vapor or oxygen, and the water-reactive substance can be suitably applied to the filling of the oxidizable substance.
  • the hard capsule of the present invention is characterized in that polyvinyl alcohol (PVA) and polyvinyl alcohol copolymer (PVA copolymer) are used in combination as components for forming a hard capsule film (capsule film). To do.
  • PVA polyvinyl alcohol
  • PVA copolymer polyvinyl alcohol copolymer
  • PVA is a polymer obtained by saponifying polyvinyl acetate.
  • the saponification degree is 97 mol% or more and a complete saponification product represented by the following formula (1), the saponification degree is 78 to 96 mol%, and the following formula:
  • any of the above-mentioned completely saponified product and partially saponified product can be used, and is not particularly limited.
  • a partially saponified product having a saponification degree of 78 to 96 mol%, particularly about 86 to 90 mol% is preferably used. It is done.
  • the degree of polymerization (n) of PVA is not particularly limited as long as it is within a range where film forming ability can be exhibited, but it is usually preferably about 400 to 3300, particularly about 400 to 2000.
  • the weight average molecular weight of the PVA is calculated from the degree of polymerization and the degree of saponification to be about 18000 to about 175000, but is not particularly limited thereto.
  • Examples of the PVA copolymer include a PVA copolymer obtained by copolymerizing a polymerizable vinyl monomer with the aforementioned PVA or a derivative thereof.
  • examples of PVA derivatives include known PVA derivatives such as amine-modified PVA, ethylene-modified PVA, and PVA having a thiol group at the terminal (terminal thiol-modified PVA). Terminal thiol-modified PVA is preferred.
  • Examples of the polymerizable vinyl monomer include (1) acrylic acid, methacrylic acid, fumaric acid, maleic acid, itaconic acid; (2) sodium salt, potassium salt, ammonium salt or alkylamine salt of the compound described in (1) above. (3) methyl methacrylate, methyl acrylate, ethyl methacrylate, ethyl acrylate, butyl methacrylate, butyl acrylate, isobutyl methacrylate, isobutyl acrylate, cyclohexyl methacrylate, cyclohexyl acrylate, 2-ethylhexyl methacrylate, 2-ethylhexyl acrylate, acrylonitrile, acrylamide, Dimethylacrylamide, styrene, vinyl acetate, hydroxyethyl methacrylate, hydroxyethyl acrylate, polyethylene glycol and methacrylic acid Ester, esters of polyethylene glycol and acrylic acid, esters of poly
  • the polymerizable vinyl monomer is preferably a combination of at least one compound selected from the group consisting of (1) and (2) and at least one compound selected from the group consisting of (3). used. Particularly preferred is a combination use of acrylic acid or methacrylic acid and methyl methacrylate.
  • the PVA copolymer is preferably a polymer copolymer obtained by copolymerizing acrylic acid and methyl methacrylate with the above-described partially saponified PVA as a skeleton.
  • Specific examples of such polymer copolymers include POVACOAT (POVACOAT (registered trademark) Type F, Type R, and Type L (manufactured by Daido Kasei Co., Ltd.)) used in the experimental examples and examples described below. it can.
  • the ratio is preferably 99: 1 to 1:99, more preferably 90:10 to 1:99, and still more preferably 80:20 to 1:99.
  • the ratio of the PVA copolymer to PVA is 50:50 to 1: 100, preferably 50:50 to 1:99, the viscosity of the capsule preparation liquid (52 ° C.
  • the ratio of PVA copolymer to PVA is 40:60 to 1: 100, preferably 40:60 to 1:99
  • the viscosity of the capsule preparation liquid (52 ° C.) Is reduced to about 1350 Pa ⁇ s or less, and accordingly, the production yield (%) of the hard capsule is also improved to 90% or more.
  • the ratio of the PVA copolymer and PVA (total amount) contained in the hard capsule (capsule film) used in the present invention is not particularly limited, but when the weight of the capsule film excluding moisture is 100% by weight, The ratio can be 70 to 99.9% by weight, preferably 80 to 99.7% by weight, and more preferably 90 to 99.5% by weight.
  • the hard capsule (capsule film) of the present invention in addition to the PVA copolymer and PVA, at least one selected from the group consisting of organic acids and salts thereof may be blended.
  • organic acid salt include, but are not limited to, edible organic acids such as acetic acid, tartaric acid, lactic acid, malic acid, succinic acid and succinic acid, or alkali metal salts thereof, particularly sodium salt and potassium salt. .
  • Acetic acid and tartaric acid or sodium and potassium salts thereof are preferred, and sodium acetate and sodium tartrate are more preferred. These may be used alone or in any combination of two or more.
  • organic acids and / or salts thereof are not limited, but usually, the organic acid and / or PVA copolymer and PVA contained in the hard capsule and the organic acid and / or salt thereof in a total amount of 100% by weight.
  • the salt (total amount) is used in such a proportion that it is contained in an amount of 0.1 to 19% by weight, preferably 0.15 to 8% by weight in terms of the proportion of the organic acid.
  • the proportion is more preferably 0.2 to 3% by weight, particularly preferably 0.5 to 1% by weight.
  • a gelling agent can also be blended in the hard capsule (capsule film) used in the present invention.
  • the gelling agent used here include carrageenan, tamarind seed polysaccharide, pectin, xanthan gum, locust bean gum, curdlan, gelatin, fur celerane, agar, and gellan gum. These may be used alone or in any combination of two or more.
  • carrageenan is an optimal gelling agent because of its high gel strength and excellent gelling properties when used in a small amount in the presence of specific ions.
  • three types of carrageenan are known: kappa-carrageenan, iota-carrageenan, and lambda-carrageenan.
  • kappa and iota-carrageenan having gelling ability can be preferably used.
  • Pectin can be classified into LM pectin and HM pectin depending on the degree of esterification, and gellan gum can be classified into acylated gellan gum (native gellan gum) and deacylated gellan gum according to the presence or absence of acylation. Can also be used without distinction.
  • a gelling aid can be used depending on the type of gelling agent used.
  • kappa-carrageenan can give one or more of potassium ion, ammonium ion and calcium ion in water.
  • compounds such as potassium chloride, potassium phosphate, ammonium chloride, ammonium acetate, calcium chloride.
  • calcium ion can be given in water, for example, calcium chloride.
  • a gelling adjuvant that can be used in combination when gellan gum is used as a gelling agent
  • carrageenan As the gelling agent used in combination, carrageenan, tamarind seed polysaccharide, xanthan gum, locust bean gum, and gellan gum are preferable, and carrageenan is particularly preferable.
  • potassium chloride can be illustrated suitably as a gelatinization adjuvant which uses this together.
  • the content is 0.05 to 10% by weight when the weight of the capsule film excluding moisture is 100% by weight.
  • 0.1 to 5% by weight more preferably 0.2 to 2.5% by weight, and still more preferably 0.3 to 2% by weight.
  • a gelling aid such as potassium chloride
  • the content thereof is in the range of 2.2% by weight or less, preferably 0.1 to 1.5% by weight, more preferably 0.2 to 1% by weight, Preferably, 0.3 to 0.8% by weight can be mentioned.
  • the hard capsule (capsule film) needs Depending on the case, a plasticizer, a metal sequestering agent, an opacifying agent, a coloring agent or a fragrance can be blended.
  • the plasticizer is not particularly limited as long as it can be used for pharmaceuticals or foods.
  • the content in the hard capsule (capsule film) used in the present invention is usually 15% by weight or less when the weight of the capsule film excluding moisture is 100% by weight. Can do. Preferably it is 13 weight% or less, More preferably, it is 11 weight% or less, More preferably, it is the range of 8 weight% or less.
  • ethylenediaminetetraacetic acid ethylenediaminetetraacetic acid, acetic acid, boric acid, citric acid, gluconic acid, lactic acid, phosphoric acid, tartaric acid, or salts thereof, metaphosphate, dihydroxyethylglycine, lecithin, ⁇ -cyclodextrin, or these Combinations can be mentioned.
  • the opacifying agent and the fragrance are not particularly limited as long as they can be used for pharmaceuticals or foods.
  • the hard capsule used in the present invention can be produced by using a conventional dipping method. Specifically, an aqueous solution containing the above-described components (hereinafter referred to as “capsule preparation solution”) is used as the dipping solution.
  • the capsule molding pin can be immersed in this, and then pulled up to cool and gel the film made of the capsule preparation liquid formed on the outer surface of the capsule molding pin, and then dried.
  • the concentration of each component contained in the capsule preparation liquid can be appropriately adjusted according to the ratio of each component in the capsule film described above.
  • the total amount of the PVA copolymer and PVA can be 5 to 30% by weight, preferably 10 to 28% by weight, more preferably 16 to 24% by weight.
  • the organic acid and / or salt thereof is 0.02 to 3.8% by weight, preferably 0.04 to 1.6% by weight, more preferably 0.04 to 0% in terms of the ratio of the organic acid. 2% by weight can be mentioned.
  • the concentration in the capsule preparation liquid is 0.01 to 2% by weight, preferably 0.02 to 1% by weight, more preferably 0.03 to 0.5% by weight. it can.
  • the concentration in the capsule preparation liquid is 0.01 to 0.5% by weight, preferably 0.02 to 0.3% by weight, more preferably 0.03 to 0.3%. 2% by weight can be mentioned.
  • the amount of the solvent (water) contained in the capsule preparation liquid is not limited, but is a temperature (immersion liquid temperature) condition (30 to 80 ° C., preferably 40 to 60 ° C.) employed when the capsule molding pin is immersed. ),
  • the ratio of the viscosity of the capsule preparation liquid is 100 to 20000 mPa ⁇ s, preferably 300 to 10000 mPa ⁇ s.
  • the viscosity of the capsule preparation liquid at a temperature condition of 52 ° C. is 300 to 3600 mPa ⁇ s, more preferably 500 to 3100 mPa ⁇ s, still more preferably 500 to 2600 mPa ⁇ s, and still more preferably 500 to 2000 mPa ⁇ s.
  • the ratio is particularly preferably 500 to 1500 mPa ⁇ s.
  • the viscosity specified in the present invention is a B-type rotational viscometer.
  • the rotor number is 2, and when the viscosity is 500 mPa ⁇ s or more and less than 2000 mPa ⁇ s, the rotor number is 3 and the viscosity is 2000 mPa ⁇ s or more.
  • the viscosity is measured when the rotor number 4 is used and measured at a predetermined temperature under the conditions of a rotation speed of 60 rpm and a measurement time of 1 minute (hereinafter the same).
  • the solvent content is 60 to 90% by weight, preferably 70 to 85% by weight.
  • the dissolution order of the above-mentioned components is not limited, and the gelling agent and the gelling auxiliary agent may be prepared by dissolving the essential components (PVA and PVA copolymer) first. Or may be dissolved simultaneously.
  • the melting temperature is usually 60 ° C. or higher, it is not particularly limited.
  • the capsule preparation liquid is preferably subjected to capsule molding by the dipping method in a state where fine bubbles are removed by vacuum degassing, ultrasonic defoaming or standing, and the temperature is kept at 50 to 60 ° C.
  • the hard capsule of the present invention was soaked in the capsule preparation liquid (immersion liquid) thus prepared, and then pulled up to gel the solution adhering to the capsule molding pin, and then gelled.
  • the film is produced by drying at a temperature of about 20 to 80 ° C.
  • the hard capsule used in the present invention can be produced through the following steps.
  • Capsule molding pin in a capsule preparation liquid (immersion liquid) containing a PVA copolymer and PVA (or an organic acid and / or a salt thereof, or a gelling agent or a gelling aid, if necessary) The step of immersing (immersion step), (2) A step of pulling up the capsule molding pin from the capsule preparation solution (immersion solution) to gel the capsule preparation solution adhering to the outer surface of the pin (gelation step), (3) A step of drying the gelled capsule film (gelated film) formed on the outer surface of the capsule molding pin (drying step), (4) A step of detaching the dried capsule film (film) from the capsule molding pin (detachment step).
  • said (2) gelatinization process can be performed by heating or cooling according to the characteristic of the gelatinizer to be used.
  • a solution containing carrageenan as a gelling agent is used as a capsule preparation liquid (immersion liquid)
  • the temperature around the capsule manufacturing machine is adjusted by utilizing that the solution gels at a temperature of 50 ° C. or less.
  • the gelation step (2) is carried out by allowing the capsule preparation solution adhering to the outer surface of the capsule molding pin to stand to cool at 35 ° C. or lower, preferably 30 ° C. or lower, preferably at room temperature. Yes (cold gel method).
  • the capsule molding pin is pulled up from the capsule preparation solution (immersion liquid)
  • the capsule preparation solution attached to the outer surface of the pin is gelled.
  • the drying step (3) can be performed at a temperature of about 20 to 80 ° C. Preferably, it is performed by blowing air at 60 ° C.
  • the detachment step (4) is performed by extracting the dry capsule film formed on the surface of the capsule molding pin from the capsule molding pin.
  • the capsule film thus prepared can be provided as a hard capsule in a state where the body part and the cap part are fitted together or not fitted after being cut and adjusted to a predetermined length.
  • edible oil or the like as a release agent to the molding pin in advance, the release properties of the obtained capsule (body part and cap part) are improved, and the obtained hard capsule can be easily peeled and collected. can do.
  • the hard capsule of the present invention is characterized by having a large elongation at break as compared with a hard capsule prepared without using PVA and a PVA copolymer in combination.
  • a breaking elongation in the range of 5 to 20 mm is usually required, and the breaking elongation is preferably as large as possible with a maximum stress in the range of 70 to 130 N.
  • the thickness is preferably 8 to 20 mm, more preferably 8.5 to 20 mm, still more preferably 9 to 20 mm, and still more preferably 9.5 to 20 mm.
  • the maximum stress is not particularly limited as long as it is within the above range, but is preferably 75 to 130N, more preferably 80 to 130N.
  • the maximum stress (N) and elongation at break (mm) were measured using an autograph AGS-J (manufactured by Shimadzu Corporation), a tensile speed of 150 mm / min, a distance between chucks of 20 mm, a tensile distance of 20 mm, 23 ° C. It can be determined by a tensile test performed in an environment with a relative humidity of 40%.
  • the maximum stress means the maximum value of the stress measured by such a method
  • the elongation at break means the tensile stroke at 1/3 of the maximum stress (see FIG. 1).
  • the target capsule (capsule film) was dried at 60 ° C. for 2 hours and then stored at 23 ° C. in an environment of 40% relative humidity for 1 week. Later, a tensile test was performed using the above conditions (Autograph AGS-J (manufactured by Shimadzu Corporation) under the environment of a tensile speed of 150 mm / min, a distance between chucks of 20 mm, a tensile distance of 20 mm, 23 ° C., and a relative humidity of 40%). Is the value obtained.
  • Hard capsule and its preparation method The body part and the cap part of the hard capsule thus prepared are filled with the above-mentioned contents, and then the body part is covered with the cap part to fit them together. Can be provided as a hard capsule.
  • the hard capsule of the present invention includes those obtained by attaching a band seal to the fitting part of the body part and the cap part of the hard capsule prepared above.
  • a hard capsule after fitting and joining the body part and the cap part, around the end edge part of the cap part, on the surface of the body part and the surface of the cap part with a constant width so as to straddle it, It can be prepared by applying the band seal preparation solution once to a plurality of times, preferably once or twice in the circumferential direction and sealing the fitting portion.
  • the fitting width where the outer circumference of the body part and the inner circumference of the cap part overlap is the distance in the axial direction of the capsule.
  • About 4 to 6 mm is generally preferred for 4.5-6.5 mm, No. 4 capsules.
  • the sealing width is generally about 1.5 to 3 mm for the No. 3 capsule and about 1.5 to 2.8 mm for the No. 4 capsule.
  • the band seal formation of the hard capsule of the present invention is not limited as long as it has at least band sealability, but preferably PVA copolymer, PVA, or PVA copolymer having the same composition as the hard capsule described above.
  • a band seal preparation solution containing a polymer and PVA also used in combination with an organic acid and / or a salt thereof, or a gelling agent or a gelling aid as required is used.
  • sorbitol can also be blended in the band seal preparation liquid as a plasticizer.
  • a plasticizer sorbitol
  • the blending ratio of sorbitol in the band seal is not particularly limited as long as it does not impair the band sealability of the PVA or / PVA copolymer, but in terms of the above effects, the band seal (in terms of dry weight: 100% by weight) ) In the range of 0.01 to 70% by weight, preferably 0.01 to 35% by weight, more preferably 0.01 to 30% by weight, and particularly preferably 1 to 30% by weight.
  • band sealability means that a film for sealing (sealing) the body part and the cap part of a hard capsule can be formed (film forming ability), and the body is sealed by sealing with this film. It means the property of the band seal that can prevent the contents from leaking out from the fitting portion between the cap portion and the cap portion (leakage prevention capability).
  • the presence or absence of the “band sealability” is determined by sealing the cap part of the capsule filled with polyethylene glycol (PEG400) with an average molecular weight of 400 (PEG400) and the fitting part of the body part using the target band seal preparation solution (band seal) When this is left on a white copy paper for 12 hours in an environment of 25 ° C. and a relative humidity of 40%, it can be evaluated by whether or not the contents leak from the band seal portion.
  • PEG400 polyethylene glycol
  • band seal target band seal preparation solution
  • the presence or absence of leakage of the contents can be determined from the following criteria as shown in Experimental Example 5: (a) Whether the contents (PEG400) are attached to the surface of the white copy paper that has been in contact with the sealed hard capsule after standing for 12 hours. (b) Whether the contents (PEG400) adhere to the white copy paper surface when the sealed hard capsule is rolled on the white copy paper after being left for 12 hours.
  • the hard capsule which uses the PVA copolymer as a base material described in Experimental Example 5 mentioned later, or the hard capsule which uses PVA as a base material can be mentioned.
  • the amount of PEG 400 filled therein may be 600 ⁇ L when the hard capsule is a size 0 capsule defined by the Japanese Pharmacopoeia, and 470 ⁇ L when the hard capsule is a size 1 capsule.
  • the band seal is optionally colored (for example, titanium oxide, bengara, tar colorant, etc.), opaque, as long as the effect of the present invention, ie, the band sealability is not hindered.
  • Additives usually used in the preparation of hard capsules such as agents or fragrances can also be blended.
  • the blending ratio of these additives to the band seal can be appropriately selected from the range of usually 0.1 to 7% by weight in consideration of the band sealing property.
  • a band seal preparation solution is usually used.
  • the band seal preparation solution is prepared by dissolving the above band seal component in water, a hydrophilic solvent, or a mixture of water and a hydrophilic solvent at room temperature or under heating (about 30 to 60 ° C.). can do.
  • a mixed solution of water and a hydrophilic solvent is used.
  • the hydrophilic solvent include organic solvents compatible with water, and specific examples include lower alcohols such as ethanol and isopropanol. Ethanol is preferable.
  • the ratio of the hydrophilic solvent in 100% by weight of the mixed liquid is 5 to 80% by weight, preferably 8 to 65% by weight, more preferably May be 10 to 50% by weight.
  • the band seal preparation liquid is adjusted so that the final viscosity of the preparation liquid is usually in the range of 100 to 5000 mPa ⁇ s under the condition of 23 ° C.
  • the viscosity is a B-type rotational viscometer.
  • the rotor number is 2
  • the viscosity is 500 mPa ⁇ s or more and less than 2000 mPa ⁇ s
  • the rotor number is 3
  • the viscosity is 2000 mPa ⁇ s or more
  • the rotor is The number 4 is used to mean the viscosity when measured under the conditions of 23 ° C., rotation speed 60 rpm, and measurement time 1 minute.
  • the band seal preparation liquid in the range where the viscosity is applied, a strong band seal with a large sealing force (sealing force) can be formed in the fitting part of the hard capsule body and cap part, and at the time of manufacture There is no stringing and the handling in production is easy. If the viscosity of the band seal preparation liquid is significantly lower than the above range (100 to 5000 mPa ⁇ s, 23 ° C.), the band seal preparation liquid may be applied without dripping onto the fitting surface of the hard capsule. It may be difficult to form a band seal excellent in sealing power.
  • the viscosity of the band seal preparation liquid when the viscosity of the band seal preparation liquid is significantly higher than the above range (100 to 5000 mPa ⁇ s, 23 ° C.), the viscosity may be too high to form a band seal with a machine.
  • the preferred viscosity of the band seal preparation liquid is 125 to 4700 mPa ⁇ s, more preferably 150 to 4500 mPa ⁇ s, at 23 ° C.
  • the viscosity of the band seal preparation liquid can be easily adjusted by adjusting the concentration of the PVA copolymer, PVA or a mixture thereof mixed in the band seal preparation liquid, or the mixing ratio of both. Specifically, the viscosity tends to decrease as the proportion of PVA used in combination with the PVA copolymer is increased.
  • the concentration of PVA in the band seal preparation liquid is usually 4 to 31% by weight, preferably 5 to 30% by weight, more preferably 6%, although it depends on the type of PVA copolymer and PVA to be blended and the degree of polymerization.
  • the concentration of PVA copolymer is usually from 5 to 27% by weight, preferably from 6 to 26% by weight, more preferably from 7 to 25% by weight.
  • the viscosity can be adjusted in consideration of the viscosity (100 to 5000 mPa ⁇ s, 23 ° C.) on the basis of the ratio of each component.
  • the concentration in the band seal preparation liquid can be determined according to the blending ratio of sorbitol in the band seal described above. Specifically, the sorbitol concentration in the band seal (100 wt%) is 0.01 to 70 wt%, preferably while considering that the viscosity of the band seal preparation solution is in the range of 100 to 5000 mPa ⁇ s. It is preferable to adjust the band seal preparation solution so as to be 0.01 to 35% by weight, more preferably 0.01 to 30% by weight, and particularly preferably 1 to 30% by weight.
  • Such a band seal is suitable as a band seal of a hard capsule in which the hard capsule of the present invention is filled with polyethylene glycol (PEG) or a composition containing the same.
  • PEG polyethylene glycol
  • the PEG is not particularly limited, and the PEG having an average molecular weight of about 20000 or less, specifically, the average molecular weight is 200, 300, 400, 600, 800, 1000, 1500, 2000, 3000, 4000, Mention may be made of 6000, 8000 or 20000 PEG.
  • PEG having each of these average molecular weights can be obtained from each manufacturer according to Japanese Pharmacopoeia and pharmaceutical additive standards (see “Japanese Pharmacopoeia” and “Pharmaceutical Additives Standards”).
  • XX indicates the approximate average molecular weight of the above-mentioned PEG).
  • Such PEG can be used individually by 1 type or in combination of 2 or more types.
  • low molecular weight PEG such as PEG having an average molecular weight of 200 to 600 (also referred to as “PEG 200 to 600”) is a PEG that is suitably used as a filling component of a hard capsule in the use of the band seal of the present invention. That is, according to the band seal of the present invention, there is no problem of bleeding even when PEG 200 to 600 is filled, and the effect of the present invention can be enjoyed more effectively.
  • the average molecular weight of PEG can be measured according to the following test according to the standards defined in “Japanese Pharmacopoeia” and “Pharmaceutical Additives Standard”.
  • PEG 200 has an average molecular weight in the range of about 190-210
  • PEG 300 has an average molecular weight in the range of about 285-315
  • PEG 400 has an average molecular weight in the range of about 380-420
  • PEG 600 has an average molecular weight of about It can be determined as being in the range of 570 to 630.
  • the content of the hard capsule may be PEG or a composition containing at least PEG as described above, and as such a composition, human or animal pharmaceuticals, quasi drugs, cosmetics, and foods containing PEG are included. Can be mentioned without limitation.
  • the proportion of PEG contained in such a composition is not particularly limited, but is usually 0.1 to 99.9% by weight, preferably 1 to 99.9% by weight, more preferably 10 to 99.9% by weight, still more preferably. 50 to 99.9% by weight can be mentioned.
  • the shape of the contents is not particularly limited.
  • it may be a liquid, gel, powder, granule, tablet, pellet, or a mixed form (hybrid) thereof.
  • tonics for example, nourishing tonics, antipyretic analgesics, antipsychotics, anxiolytics, antidepressants, hypnotic sedatives, antispasmodics, central nervous system drugs, brain Metabolic improver, cerebral circulation modifier, antiepileptic agent, sympathomimetic agent, gastrointestinal agent, antacid, antiulcer agent, antitussive expectorant, antiemetic agent, respiratory accelerator, bronchodilator, allergic agent, dental oral cavity Drugs, antihistamines, cardiotonic drugs, arrhythmia drugs, diuretics.
  • docosahexaenoic acid for example, docosahexaenoic acid, eicosapentaenoic acid, ⁇ -lipoic acid, royal jelly, isoflavone, agaricus, acerola, aloe, aloe vera, turmeric, ercarnitine, oligosaccharide, cacao, catechin, capsaicin, chamomile, agar, Tocopherol, linolenic acid, xylitol, chitosan, GABA, citric acid, chlorella, glucosamine, ginseng, coenzyme Q10, brown sugar, collagen, chondroitin, sorghum, squalene, stevia, ceramide, taurine, saponin, lecithin, dextrin, dodomi, niacin, Natto, bittern, lactic acid bacteria, saw palmetto, honey, hatomugi, plum extract, pantothenic acid,
  • Filling of the contents into the hard capsule may be performed by a capsule filling machine known per se, for example, a fully automatic capsule filling machine (model name: LIQFILsuper 80/150, manufactured by Qualicaps), a capsule filling / sealing machine (model name: LIQFILsuperFS, Qualicaps Co., Ltd.) can be used.
  • sealing of hard capsules can be carried out using a capsule filling and sealing machine known per se, such as the capsule filling and sealing machine or capsule sealing machine (model name: HICAPSEALSE40 / 100, manufactured by Qualicaps Co., Ltd.). .
  • the band seal preparation liquid can be generally used at room temperature or under heating. From the viewpoint of preventing liquid leakage of the hard capsule, it is desirable to use a seal preparation liquid preferably within a temperature range of about 23 to 45 ° C, more preferably about 23 to 35 ° C, and most preferably about 25 to 35 ° C.
  • the temperature adjustment of the seal preparation liquid can be carried out by a method known per se such as a panel heater and a hot water heater. For example, a circulating hot water heater or a seal pan unit of the integrated capsule filling and sealing machine is circulated. It is preferable to adjust with a hot water heater type modified because the temperature range can be finely adjusted.
  • alcohol for example, ethanol in the seal preparation liquid may volatilize depending on temperature conditions, it is preferable to appropriately replenish the component composition of the seal preparation liquid.
  • the thus obtained hard capsule of the present invention is excellent in operability without leaching even when PEG, particularly low molecular weight PEG having an average molecular weight of 200 to 600 is filled therein.
  • PEG particularly low molecular weight PEG having an average molecular weight of 200 to 600 is filled therein.
  • the film does not become brittle even when glycerin fatty acid ester or medium chain fatty acid triglyceride of low molecular weight PEG is filled, these low molecular weight PEG, its glycerin fatty acid ester and medium chain fatty acid triglyceride are used as excipients. It can be applied well to drugs that contain it. In addition, good strength can be maintained even when the water content in the film is reduced, and there is no inconvenience such as cracking. Therefore, it is also suitable for use in drugs that have water absorption or recommended to be stored under low moisture. Furthermore, since water vapor and oxygen hardly permeate, it is preferably used for water-reactive substances and oxidizable
  • the present invention provides a method for improving the elongation at break for a capsule film (film) containing a PVA copolymer.
  • a PVA copolymer and PVA are used in combination, and at least one selected from PVA copolymer, PVA, and an organic acid and a salt thereof. It can carry out by using together.
  • the types of organic acids and / or their salts used in combination therewith can be the same as those described in I.
  • the ratio of the organic acid and / or salt thereof used in combination with PVA and the PVA copolymer is not particularly limited.
  • the ratio of the organic acid and / or salt (total amount) contained in 100% by weight of the total amount of the PVA and PVA copolymer and organic acid and / or salt thereof is 0 in terms of the amount of organic acid.
  • the ratio can be raised to 0.1 to 19% by weight, preferably 0.15 to 8% by weight, more preferably 0.2 to 3% by weight, and particularly preferably 0.5 to 1% by weight.
  • the capsule film contains a gelling agent as described in I. It is also possible to add a gelling aid as necessary. Those types and blending ratios can also be the same as those described in I above.
  • the above components may be included in the capsule film as long as the effects of the present invention are not impaired.
  • a gelling aid if necessary, a plasticizer, a metal sequestering agent, an opacifying agent, a coloring agent or a fragrance can be blended.
  • Hard capsules obtained by applying the method for improving elongation at break of the present invention are hard capsules prepared without using PVA (hard capsules prepared by the same formulation and manufacturing method except that PVA is not used, hereinafter referred to as “control capsule”. Since the elongation at break is larger than that of the other), cracks and cracks are less likely to occur even under low moisture, and it is excellent in crack resistance and impact resistance. As described above, the hard capsule is usually required to have a breaking elongation in the range of 5 mm to 20 mm. The breaking elongation is preferably as large as possible with the maximum stress in the range of 70 to 130 N.
  • the breaking elongation is preferably 8 to 20 mm, more preferably 8.5 to 20 mm, still more preferably 9 to 20 mm, and still more preferably 9.5 to 20 mm.
  • “under low moisture” means that the moisture content (%) of the capsule film is usually 5% or less, preferably 3 to 5%, more preferably 3 to 4%.
  • the moisture content (%) of the capsule film can be measured according to the method described in Experimental Example 2 (2).
  • PVA polyvinyl alcohol
  • a capsule preparation solution containing 144% and potassium chloride (gelling aid) 0.072% was prepared, and this was applied to a glass plate using a film making applicator so that the dry thickness was 0.1 mm. Casting. This was dried at 60 ° C. for 2 hours and stored for one week in an environment of 23 ° C. and relative humidity of 40%, and then cut into a film having a length of 70 mm and a width of 10 mm to obtain a test film.
  • the tensile test was performed using an autograph AGS-J (manufactured by Shimadzu Corporation) in an environment where the tensile speed was 150 mm / min, the distance between chucks was 20 mm, the tensile distance was 20 mm, 23 ° C., and the relative humidity was 40%.
  • the maximum stress (N) and elongation at break (mm) were measured.
  • FIG. 1 shows a stress-strain curve obtained in this tensile test.
  • the maximum value of the stress (N) thus obtained corresponds to the “maximum stress” in the present invention, and the tensile stroke (tensile distance) at 1/3 of the maximum stress corresponds to the “breaking elongation” in the present invention. Equivalent to.
  • the stress at a tensile distance of 20 mm was 1/3 or more of the maximum stress
  • the elongation at break was 20 mm.
  • the viscosity (mPa ⁇ s) at 52 ° C. of the capsule preparation liquid, the water content (%), the maximum stress (N), and the elongation at break (mm) of the prepared capsule film were measured according to the following methods.
  • Viscosity (mPa ⁇ s) of capsule preparation liquid 52 ° C
  • the viscosity was measured using a B-type rotational viscometer (rotor number 3) under the conditions of 52 ° C., a rotation speed of 12 rpm, and a measurement time of 1 minute.
  • each measurement result is shown in Table 2 together with the ratio of PVA, PVA copolymer and organic acid salt of each capsule film (converted with the total amount of these components as 100% by weight).
  • the converted organic acid% means the amount of the added organic acid salt is converted into the amount of the organic acid and made a percentage with respect to the total amount.
  • FIGS. 3 to 13 show the comparison results of the measurement results of the stress (N) and the tensile stroke (mm) of the sample 1 not containing PVA and the measurement results of the samples 2 to 12 containing PVA, respectively.
  • the PVA copolymer can be combined with PVA or PVA and an organic acid salt to reduce the moisture content to 5% or less. It is considered that a hard capsule that is resistant to impact and hard to crack even under moisture conditions can be prepared.
  • Capsule production yield (%) is determined by a visual inspection machine that sorts out defective products such as bubbles in capsule film and deformation of capsules for hard capsules that have been created. The number of capsules per unit time (number of non-defective products after visual inspection) and the number of theoretical capsules manufactured per unit time (the number of theoretical capsules manufactured) were calculated according to the following formula.
  • the production yield exceeds 50% by setting the viscosity (52 ° C) of the capsule preparation liquid to about 3100 mPa ⁇ s or less, and further to about 2000 mPa ⁇ s or less.
  • the production yield exceeds 80%, and in particular, the production yield exceeds 90% by setting it to about 1500 mPa ⁇ s or less, particularly 1350 ⁇ mPa ⁇ s or less (see FIG. 14 and Table 3).
  • the capsule preparation liquid when the blending ratio of the PVA copolymer and PVA is particularly 50:50 to 1: 100, the capsule preparation liquid has a viscosity of about 1500 mPa ⁇ s or less and 40:60 to 1: 100.
  • the viscosity of the preparation liquid can be adjusted to about 1350 mPa ⁇ s or less, and as a result, the production yield of capsules can be increased to 90% or more.
  • aqueous solution thus prepared (capsule preparation solution) as an immersion liquid
  • capsule preparation solution aqueous solution
  • the size 1 hard capsule was maintained according to a conventional method while maintaining the temperature of the immersion liquid at 50 to 55 ° C. (Cap, body) was prepared.
  • the hard capsule water content (%) was determined for each of the hard capsules prepared above and stored for 1 week in an environment of 23 ° C., 12%, 22%, 33%, 43% and 53% relative humidity. Specifically, first, the weight (wet weight) of the hard capsules after the storage was measured, and then dried by heating at 105 ° C. for 2 hours, and the weight (dry weight) of each hard capsule was measured again. Next, the ratio of the amount of water that decreases by heating and drying at 105 ° C. for 2 hours according to the following formula from the difference between the weight before drying (wet weight) and the weight after drying (dry weight) (hard capsule moisture amount%) was calculated.
  • Hard capsule crack rate (%) Each hard capsule prepared above was stored for 1 week in an environment of 23 ° C., 12%, 22%, 33%, 43% and 53% relative humidity, and the cracking rate (%) of the hard capsule was determined. Specifically, a 50 g weight was naturally dropped from a height of 10 cm to each hard capsule after the storage, and the number of broken hard capsules was counted. The cracking rate (%) of the hard capsules was calculated from the number of broken hard capsules according to the following formula.
  • the obtained band seal preparation liquid was filled with 470 ⁇ L of PEG400 into a hard capsule prepared according to the method of Example 1 using a fully automatic capsule filling and sealing machine (manufactured by Qualicaps Co., Ltd.), and the above band seal preparation was performed.
  • the body part of the hard capsule and the fitting part of the cap part were sealed with a liquid to prepare a hard capsule.
  • the appearance of the sealed hard capsule was visually observed to observe the presence or absence of leakage or sorbitol precipitation, and in accordance with the following method, the temperature was 25 ° C. and the relative humidity was 40%.
  • the band sealability was evaluated from the presence or absence of leakage of the contents after standing for a period of time.
  • Viscosity of the band seal preparation liquid is measured using a B-type rotational viscometer (rotor number 2 when the viscosity is less than 500 mPa ⁇ s, rotor number 3 when the viscosity is 500 mPa ⁇ s to less than 2000 mPa ⁇ s, and viscosity is 2000 mPa In the case of s or more, the measurement was performed using a rotor number 4) under the conditions of 23 ° C., rotation speed 60 rpm, and measurement time 1 minute.
  • each sealed hard capsule was left on a white copy paper for 12 hours in an environment of a temperature of 25 ° C. and a relative humidity of 40%. After 12 hours, the presence or absence of leakage of the contents (PEG400) from the band seal part was confirmed by the following method and criteria.
  • band sealability: ⁇ when there is no adhesion of the contents to the white copy paper, that is, no leakage of the contents is recognized, “band sealability: ⁇ ”, (a) and (b) In any of the cases, the case where leakage of the contents is recognized is determined as “no band sealability: x”.
  • the PVA and PVA copolymer can be suitably used as a band seal raw material alone or as a mixture thereof, and even when sorbitol is blended in a proportion of 70% by weight or less, It turned out that it can be used conveniently.
  • the blending ratio of sorbitol is not particularly problematic if it is 70% by weight or less from the viewpoint of band sealability, but less than 40% by weight, preferably 35% by weight or less, more preferably from the point of precipitation of sorbitol. It is preferable that it is 30 weight% or less.
  • Example 1 Preparation of hard capsule (1) Preparation of hard capsule 48 kg of PVA (partially saponified PVA, polymerization degree 1000, saponification degree 86-90 mol%, manufactured by Wako Pure Chemical Industries, Ltd.) in 170 L of purified water at 40 ° C. In addition, the mixture was dispersed and heated to 82 ° C. to dissolve the PVA. This was cooled to 60 ° C. to prepare an aqueous PVA solution.
  • PVA partially saponified PVA, polymerization degree 1000, saponification degree 86-90 mol%, manufactured by Wako Pure Chemical Industries, Ltd.

Abstract

A hard capsule made by using a polyvinyl alcohol copolymer as the film component, which is improved in the breaking extension of capsule film with the maximum stress of the film kept at a prescribed level and is thereby enhanced in fracture resistance and impact resistance. The hard capsule is characterized by being made of a capsule film prepared from a combination of a polyvinyl alcohol copolymer with polyvinyl alcohol.

Description

硬質カプセル剤Hard capsule
 本発明は、ポリビニルアルコール共重合体をカプセルフィルム成分とする硬質カプセルの改良に関する。より詳細には、本発明は、当該硬質カプセルのカプセルフィルム(皮膜)の破断伸びを向上させることによって、耐割れ性や耐衝撃性を向上させた硬質カプセル、およびその調製方法に関する。さらに本発明は、当該硬質カプセルに医薬品や食品などの内容物が充填されてなる硬質カプセル剤およびその調製方法に関する。 This invention relates to the improvement of the hard capsule which uses a polyvinyl alcohol copolymer as a capsule film component. More specifically, the present invention relates to a hard capsule having improved crack resistance and impact resistance by improving the elongation at break of the capsule film (film) of the hard capsule, and a method for preparing the same. Furthermore, the present invention relates to a hard capsule obtained by filling the hard capsule with contents such as pharmaceuticals and foods, and a method for preparing the same.
 医薬品や食品などの固形製剤の一つとして硬質カプセル剤がある。このものは、通常ゼラチン皮膜で形成された互いに一端の開いた帽状容体の内部に粉末、顆粒または液状(油状)の医薬成分または食品成分を所定量充填した後、それら容体を同軸的に結合して完成される。かかる硬質ゼラチンカプセル剤は、製剤化のしやすさと医薬成分や食品成分の矯味および/または矯臭作用による服用のし易さから汎用されている製剤である。 There is a hard capsule as one of solid preparations such as pharmaceuticals and foods. This is usually filled with a powder, granule, or liquid (oil) pharmaceutical ingredient or food ingredient in a cap-like container, which is usually formed of a gelatin film, and open at one end. And completed. Such hard gelatin capsules are widely used because they are easy to formulate and easy to take due to the taste-masking and / or taste-masking action of pharmaceutical ingredients and food ingredients.
 しかし、当該硬質ゼラチンカプセル剤に使用されるゼラチンフィルム(皮膜)は、それに含まれる水分が少なくなると極端にその機械的強度が低下するといった欠点を有している。具体的には、硬質ゼラチンカプセル剤は、皮膜中に通常13~15%程度の水分を保有しているが、これが10%以下になると皮膜の柔軟性が低下して極めて脆くなる。このため、吸水性を有していたり水反応性を有する薬剤や食品など、保存条件として低水分環境が求められる内容物を充填した場合に、ひび、割れまたは欠けなど、カプセルフィルム(皮膜)に損傷を生じることがある。かかる問題を解消するための方策として、基材に水溶性セルロース誘導体、特にヒドロキシプロピルメチルセルロース(以下、「HPMC」という)を用いたカプセル(特許文献1)が提案されている。しかし、HPMCに平均分子量が200~600の低分子量ポリエチレングリコール(以下、「低分子量PEG」という)を充填すると低分子量PEGがカプセルフィルム(皮膜)を通過して漏れ出してしまうことが観察されることが指摘されており(特許文献2参照)、低分子量PEGやこれを含む組成物は内容物としては適用することができない。また、HPMCを用いたカプセルフィルムは水蒸気や酸素が透過しやすいため、内容物が劣化することも指摘されている(特許文献2参照)。 However, the gelatin film (coating) used in the hard gelatin capsule has a drawback that its mechanical strength is extremely lowered when the moisture contained therein is reduced. Specifically, hard gelatin capsules usually contain about 13 to 15% of moisture in the film, but if this is less than 10%, the film becomes less flexible and extremely brittle. For this reason, when filled with contents that require a low moisture environment as storage conditions, such as water-absorbing or water-reactive drugs and foods, the capsule film (film) will be cracked, cracked or chipped. May cause damage. As a measure for solving this problem, a capsule (Patent Document 1) using a water-soluble cellulose derivative, particularly hydroxypropylmethylcellulose (hereinafter referred to as “HPMC”) as a base material has been proposed. However, when HPMC is filled with low molecular weight polyethylene glycol having an average molecular weight of 200 to 600 (hereinafter referred to as “low molecular weight PEG”), it is observed that the low molecular weight PEG leaks through the capsule film (film). It is pointed out (see Patent Document 2), and low molecular weight PEG and compositions containing the same cannot be applied as contents. Moreover, since the capsule film using HPMC is easy to permeate | transmit water vapor | steam and oxygen, it has also been pointed out that a content deteriorates (refer patent document 2).
 このため、低水分下でも良好な皮膜強度を確実に維持することができ、また低分子量PEGやそのグリセリン脂肪酸エステルおよび中鎖脂肪酸トリグリセリドなどの油脂類も不都合なく充填することができ、かつ水蒸気や酸素の透過もなく、水反応性物質や被酸化性物質の充填にも好適に適用することができる硬質カプセルとして、ポリビニルアルコールやその共重合体が提案されている(特許文献2~4など参照)。
特開平3-279325号公報 特開2001-170137号公報 米国特許公報(US7045184B2) 国際公開公報(WO02/017848)
Therefore, good film strength can be reliably maintained even under low moisture, and low molecular weight PEG and its fats and oils such as glycerin fatty acid ester and medium chain fatty acid triglyceride can be filled without inconvenience. Polyvinyl alcohol and copolymers thereof have been proposed as hard capsules that can be suitably applied to filling water-reactive substances and oxidizable substances without permeation of oxygen (see Patent Documents 2 to 4, etc.). ).
JP-A-3-279325 JP 2001-170137 A US Patent Gazette (US7045184B2) International Publication (WO02 / 017848)
 本発明は、かかるポリビニルアルコール共重合体をフィルム成分とする硬質カプセルについて、カプセルフィルム(皮膜)の所定の最大応力を保持しつつも破断伸び性を向上することによって、割れ耐性や衝撃耐性が強化された硬質カプセルを提供することを目的とする。 In the present invention, for a hard capsule having such a polyvinyl alcohol copolymer as a film component, the crack elongation and the impact resistance are enhanced by improving the elongation at break while maintaining a predetermined maximum stress of the capsule film (film). It is an object to provide a hard capsule.
  本発明者らは、上記目的を達成するために日夜鋭意検討していたところ、カプセルのフィルム成分として、ポリビニルアルコール共重合体(以下、「PVA共重合体」という)とポリビニルアルコール(以下、「PVA」という)とを併用することにより、またこれにさらに酢酸や酒石酸などの有機酸またはその塩を併用することによって、硬質カプセルに求められる所定の最大応力を保持しながらも、カプセルフィルムの破断伸びが向上することを見出し、その結果、より一層、割れにくく衝撃に強い硬質カプセルが調製できることを確認した。 The inventors of the present invention have been diligently studying day and night to achieve the above object, and as a film component of the capsule, polyvinyl alcohol copolymer (hereinafter referred to as “PVA copolymer”) and polyvinyl alcohol (hereinafter referred to as “ PVA ") and a combination of an organic acid such as acetic acid and tartaric acid or a salt thereof, while maintaining the predetermined maximum stress required for hard capsules, the capsule film breaks. It was found that the elongation was improved, and as a result, it was confirmed that it was possible to prepare a hard capsule that was more resistant to breakage and resistant to impact.
 本発明はかかる知見に基づいて完成されたものであり、下記の態様を含むものである。 The present invention has been completed based on such knowledge and includes the following aspects.
 (I)硬質カプセルおよびその製造方法
(I-1)PVA共重合体およびPVAを含有するフィルムからなる硬質カプセル。
(I) Hard capsule and manufacturing method thereof (I-1) A hard capsule comprising a film containing a PVA copolymer and PVA.
 (I-2)フィルムに含まれるPVA共重合体とPVAとの重量比が100:1~1:100、好ましくは99:1~1:99である、(I-1)に記載する硬質カプセル。 (I-2) The hard capsule according to (I-1), wherein the weight ratio of the PVA copolymer and PVA contained in the film is 100: 1 to 1: 100, preferably 99: 1 to 1:99 .
 (I-3)フィルムに含まれるPVA共重合体とPVAとの重量比が90:10~1:100、好ましくは90:10~1:99である、(I-1)に記載する硬質カプセル。 (I-3) The hard capsule according to (I-1), wherein the weight ratio of the PVA copolymer and PVA contained in the film is 90:10 to 1: 100, preferably 90:10 to 1:99 .
 (I-4)フィルムに含まれるPVA共重合体とPVAとの重量比が50:50~1:100、好ましくは50:50~1:99である、(I-1)に記載する硬質カプセル。 (I-4) The hard capsule according to (I-1), wherein the weight ratio of the PVA copolymer and PVA contained in the film is 50:50 to 1: 100, preferably 50:50 to 1:99 .
 (I-5)カプセルフィルムの成分として、さらに、有機酸およびその塩からなる群から選択される少なくとも1種を含有する(I-1)乃至(I-4)のいずれかに記載する硬質カプセル。 (I-5) The hard capsule according to any one of (I-1) to (I-4), which further contains at least one selected from the group consisting of organic acids and salts thereof as a component of the capsule film .
 (I-6)上記有機酸が酢酸または酒石酸である、(I-5)に記載する硬質カプセル。 (I-6) The hard capsule according to (I-5), wherein the organic acid is acetic acid or tartaric acid.
 (I-7)上記有機酸の塩が、有機酸のアルカリ金属塩である(I-5)または(I-6)に記載する硬質カプセル。 (I-7) The hard capsule described in (I-5) or (I-6), wherein the organic acid salt is an alkali metal salt of an organic acid.
 (I-8)PVA共重合体およびPVAに加えて、さらにゲル化剤を含有する(I-1)乃至(I-8)のいずれかに記載する硬質カプセル。 (I-8) The hard capsule according to any one of (I-1) to (I-8), which further contains a gelling agent in addition to the PVA copolymer and PVA.
 (I-9)さらにゲル化補助剤を含有する(I-8)に記載する硬質カプセル。 (I-9) The hard capsule described in (I-8), which further contains a gelling aid.
 (I-10)フィルムの水分量が3~5%であり、破断伸びが5~20mmであることを特徴とする(I-1)乃至(I-9)のいずれかに記載する硬質カプセル。 (I-10) The hard capsule according to any one of (I-1) to (I-9), wherein the film has a moisture content of 3 to 5% and an elongation at break of 5 to 20 mm.
 (I-11)PVA共重合体およびPVAを含有するカプセル調製液に、カプセル成型用ピンを浸漬して引き上げ、当該成型用ピンに付着した上記カプセル調製液をゲル化、乾燥させ、これを成型ピンから脱離回収して硬質カプセルを得ることを特徴とする、(I-1)乃至(I-10)のいずれかに記載する硬質カプセルの製造方法。 (I-11) Capsule molding pin is dipped in a capsule preparation liquid containing PVA copolymer and PVA, and the capsule preparation liquid attached to the molding pin is gelled and dried, and then molded. The method for producing a hard capsule according to any one of (I-1) to (I-10), wherein the hard capsule is obtained by desorbing and collecting from a pin.
 (II)硬質カプセル剤
(II-1)(I-1)乃至(I-10)のいずれかに記載する硬質カプセルに、ポリエチレングリコールまたはポリエチレングリコールを含む組成物が充填されてなる、硬質カプセル剤。
(II) Hard capsule (II-1) A hard capsule comprising the hard capsule described in any one of (I-1) to (I-10) filled with polyethylene glycol or a composition containing polyethylene glycol .
 (II-2)上記ポリエチレングリコールが、平均分子量200~600の低分子量ポリエチレングリコールである、(II-1)記載の硬質カプセル剤。 (II-2) The hard capsule according to (II-1), wherein the polyethylene glycol is a low molecular weight polyethylene glycol having an average molecular weight of 200 to 600.
 (II-3)ボディ部とキャップ部の嵌合部が、PVA共重合体、PVAまたはこれらの混合物を含有するバンドシールで封緘されてなることを特徴とする、(II-1)または(II-2)に記載する硬質カプセル剤。 (II-3) The fitting part of the body part and the cap part is sealed with a band seal containing PVA copolymer, PVA or a mixture thereof, (II-1) or (II -2) Hard capsule described in the above.
 (II-4)バンドシールが更にソルビトールを含有するものである、(II-3)に記載する硬質カプセル剤。 (II-4) The hard capsule described in (II-3), wherein the band seal further contains sorbitol.
 (II-5)(I-1)乃至(I-10)のいずれかに記載する硬質カプセル内に内容物を充填した後、キャップ部とボディ部を嵌合し、形成された嵌合部に、PVA共重合体、PVAまたはこれらの混合物を含有するバンドシール調製液を塗布し、乾燥して封緘することを特徴とする硬質カプセル剤の調製方法。 (II-5) After filling the hard capsule according to any one of (I-1) to (I-10), the cap part and the body part are fitted, and the formed fitting part is A method for preparing a hard capsule, which comprises applying a band seal preparation solution containing PVA copolymer, PVA or a mixture thereof, drying and sealing.
 (II-6)上記バンドシール調製液がさらにソルビトールを含有するものである、(II-5)に記載する調製方法。 (II-6) The preparation method according to (II-5), wherein the band seal preparation solution further contains sorbitol.
 (II-7)上記内容物がポリエチレングリコールまたはポリエチレングリコールを含む組成物である、(II-5)または(II-6)に記載する調製方法。 (II-7) The preparation method according to (II-5) or (II-6), wherein the content is polyethylene glycol or a composition containing polyethylene glycol.
 (III)カプセルフィルムの破断伸び向上方法
(III-1)PVA共重合体を含有するカプセルフィルムの破断伸び向上方法であって、フィルム成分としてPVA共重合体とPVAとを併用することを特徴とする方法。
(III) Capsule film break elongation improvement method (III-1) Capsule film break elongation improvement method containing a PVA copolymer, characterized in that a PVA copolymer and PVA are used in combination as film components. how to.
 (III-2)上記カプセルフィルムに配合する、PVA共重合体とPVAとの重量比が、100:1~1:100、好ましくは99:1~1:99である、(III-1)に記載するカプセルフィルムの破断伸び向上方法。 (III-2) The weight ratio of the PVA copolymer to PVA blended in the capsule film is 100: 1 to 1: 100, preferably 99: 1 to 1:99, (III-1) A method for improving the breaking elongation of a capsule film to be described.
 (III-3)上記カプセルフィルムに配合する、PVA共重合体とPVAとの重量比が、90:10~1:100、好ましくは90:10~1:99である、(III-1)に記載するカプセルフィルムの破断伸び向上方法。 (III-3) The weight ratio of the PVA copolymer to PVA blended in the capsule film is 90:10 to 1: 100, preferably 90:10 to 1:99. A method for improving the breaking elongation of a capsule film to be described.
 (III-4)上記カプセルフィルムに配合する、PVA共重合体とPVAとの重量比が、50:50~1:100、好ましくは50:50~1:99である、(III-1)に記載するカプセルフィルムの破断伸び向上方法。 (III-4) The weight ratio of the PVA copolymer to PVA blended in the capsule film is 50:50 to 1: 100, preferably 50:50 to 1:99. A method for improving the breaking elongation of a capsule film to be described.
 (III-5)フィルム成分としてさらに有機酸およびその塩からなる群から選択される少なくとも1種を併用することを特徴とする、(III-1)乃至(III-4)のいずれかに記載するカプセルフィルムの破断伸び向上方法。 (III-5) The film component further includes at least one selected from the group consisting of an organic acid and a salt thereof, and is described in any one of (III-1) to (III-4) Method for improving elongation at break of capsule film.
 (III-6)上記有機酸が酢酸または酒石酸である、(III-5)に記載する硬質カプセル。 (III-6) The hard capsule according to (III-5), wherein the organic acid is acetic acid or tartaric acid.
 (III-7)上記有機酸の塩が、有機酸のアルカリ金属塩である(III-5)または(III-6)に記載する硬質カプセル。 (III-7) The hard capsule described in (III-5) or (III-6), wherein the salt of the organic acid is an alkali metal salt of an organic acid.
 本発明の硬質カプセルは、フィルム成分としてPVA共重合体とPVAとを併用することによって、PVAを用いないでPVA共重合体を用いて調製したカプセルフィルム(皮膜)に比して、ほぼ同じ最大応力を備えながらも、破断伸びが向上し、その結果、低水分下でも、ひびや割れがより一層生じにくくなった硬質カプセルである(耐割れ性の向上)。耐割れ性が向上することによって、(1)カプセル製造時において、割れや欠けなどの不良品の発生が減少し、生産効率が改善する、(2)カプセル輸送時において、衝撃や振動などの物理的負荷によるカプセルの割れが減少する、および(3)充填機や外観検査機などの製剤機械を原因とする物理的負荷によるカプセルの割れが減少するといった利点がある。また、これに内容物を充填したカプセル剤においても(i)輸送時の衝撃や振動などの物理的負荷によるカプセルの割れが減少する、(ii)PTP包装されたカプセル剤を指などで押し出して取り出す際の物理的負荷によるカプセルの割れが減少するといった利点がある。 The hard capsule of the present invention has almost the same maximum as a capsule film (coating) prepared by using a PVA copolymer without using PVA by using a PVA copolymer and PVA together as a film component. Although it is provided with stress, the elongation at break is improved, and as a result, it is a hard capsule in which cracks and cracks are less likely to occur even under low moisture (improved crack resistance). Improved cracking resistance improves (1) the production of defective products such as cracks and chips during capsule production, and improves production efficiency. (2) Physical properties such as shock and vibration during transport of capsules. There are advantages in that capsule breakage due to mechanical load is reduced, and (3) capsule breakage due to physical load caused by formulation machines such as filling machines and visual inspection machines is reduced. In addition, capsules filled with the contents also reduce (i) capsule breakage due to physical loads such as impact and vibration during transportation. (Ii) Extrude PTP-packed capsules with fingers. There is an advantage that the breakage of the capsule due to the physical load at the time of taking out is reduced.
 また、本発明の硬質カプセルは、従来のPVAやPVA共重合体を用いて調製される硬質カプセル(特許文献2~4参照)と同じく、低分子量PEGやグリセリン脂肪酸エステルおよび中鎖脂肪酸トリグリセリドなどの油脂類も不都合なく充填することができ、かつ水蒸気や酸素の透過もなく、水反応性物質は被酸化性物質の充填にも好適に適用することができる。 In addition, the hard capsule of the present invention is a low-molecular-weight PEG, a glycerin fatty acid ester, a medium-chain fatty acid triglyceride, and the like, similar to a hard capsule prepared using a conventional PVA or PVA copolymer (see Patent Documents 2 to 4). Oils and fats can be filled without any inconvenience, and there is no permeation of water vapor or oxygen, and the water-reactive substance can be suitably applied to the filling of the oxidizable substance.
 I.硬質カプセルおよびその調製方法
 本発明の硬質カプセルは、硬質カプセル皮膜(カプセルフィルム)を形成する成分としてポリビニルアルコール(PVA)とポリビニルアルコール共重合体(PVA共重合体)とを併用することを特徴とする。
I. Hard capsule and method for preparing the same The hard capsule of the present invention is characterized in that polyvinyl alcohol (PVA) and polyvinyl alcohol copolymer (PVA copolymer) are used in combination as components for forming a hard capsule film (capsule film). To do.
 PVAは、ポリ酢酸ビニルをけん化して得られる重合物であり、通常、けん化度が97mol%以上で下式(1)で表される完全けん化物と、けん化度が78~96mol%で下記式(2)で表される部分けん化物とがある。本発明では、上記完全けん化物及び部分けん化物のいずれも使用することができ、特に制限されるものではないが、けん化度78~96mol%、特に86~90mol%程度の部分けん化物が好ましく用いられる。 PVA is a polymer obtained by saponifying polyvinyl acetate. Usually, the saponification degree is 97 mol% or more and a complete saponification product represented by the following formula (1), the saponification degree is 78 to 96 mol%, and the following formula: There is a partially saponified product represented by (2). In the present invention, any of the above-mentioned completely saponified product and partially saponified product can be used, and is not particularly limited. However, a partially saponified product having a saponification degree of 78 to 96 mol%, particularly about 86 to 90 mol% is preferably used. It is done.
Figure JPOXMLDOC01-appb-C000001
Figure JPOXMLDOC01-appb-C000001
Figure JPOXMLDOC01-appb-C000002
Figure JPOXMLDOC01-appb-C000002
 PVAの重合度(n)は、フィルム形成能を発揮し得る範囲であればよく、特に制限されるものではないが、通常は400~3300、特に400~2000程度であることが好ましい。なお、上記重合度とけん化度から、かかるPVAの重量平均分子量を算出すると約18000~約175000になるが、特にこれに制限されるものではない。 The degree of polymerization (n) of PVA is not particularly limited as long as it is within a range where film forming ability can be exhibited, but it is usually preferably about 400 to 3300, particularly about 400 to 2000. The weight average molecular weight of the PVA is calculated from the degree of polymerization and the degree of saponification to be about 18000 to about 175000, but is not particularly limited thereto.
 PVA共重合体としては、前述するPVAまたはその誘導体に重合性ビニル単量体を共重合させて得られるPVA共重合体を挙げることができる。ここでPVAの誘導体としては、アミン変性PVA,エチレン変性PVA、末端にチオール基を有するPVA(末端チオール変性PVA)などの公知のPVA誘導体を挙げることができる。好ましくは末端チオール変性PVAである。 Examples of the PVA copolymer include a PVA copolymer obtained by copolymerizing a polymerizable vinyl monomer with the aforementioned PVA or a derivative thereof. Here, examples of PVA derivatives include known PVA derivatives such as amine-modified PVA, ethylene-modified PVA, and PVA having a thiol group at the terminal (terminal thiol-modified PVA). Terminal thiol-modified PVA is preferred.
 重合性ビニル単量体としては、(1)アクリル酸、メタクリル酸、フマル酸、マレイン酸、イタコン酸;(2)上記(1)記載の化合物のナトリウム塩、カリウム塩、アンモニウム塩またはアルキルアミン塩;(3)メチルメタクリレート、メチルアクリレート、エチルメタクリレート、エチルアクリレート、ブチルメタクリレート、ブチルアクリレート、イソブチルメタクリレート、イソブチルアクリレート、シクロヘキシルメタクリレート、シクロヘキシルアクリルレート、2-エチルヘキシルメタクリレート、2-エチルヘキシルアクリルレート、アクリロニトリル、アクリルアミド、ジメチルアクリルアミド、スチレン、酢酸ビニル、ヒドロキシエチルメタクリレート、ヒドロキシエチルアクリレート、ポリエチレングリコールとメタクリル酸とのエステル、ポリエチレングリコールとアクリル酸とのエステル、ポリプロピレングリコールとメタクリル酸とのエステル、ポリプロピレングリコールとアクリル酸とのエステル、N-ビニルピロリドン、またはアクリロイルモルホリン;(4)下式で示される化合物: Examples of the polymerizable vinyl monomer include (1) acrylic acid, methacrylic acid, fumaric acid, maleic acid, itaconic acid; (2) sodium salt, potassium salt, ammonium salt or alkylamine salt of the compound described in (1) above. (3) methyl methacrylate, methyl acrylate, ethyl methacrylate, ethyl acrylate, butyl methacrylate, butyl acrylate, isobutyl methacrylate, isobutyl acrylate, cyclohexyl methacrylate, cyclohexyl acrylate, 2-ethylhexyl methacrylate, 2-ethylhexyl acrylate, acrylonitrile, acrylamide, Dimethylacrylamide, styrene, vinyl acetate, hydroxyethyl methacrylate, hydroxyethyl acrylate, polyethylene glycol and methacrylic acid Ester, esters of polyethylene glycol and acrylic acid, esters of polypropylene glycol and methacrylic acid, esters of polypropylene glycol and acrylic acid, N- vinyl pyrrolidone or acryloyl morpholine; (4) a compound represented by the following formula:
Figure JPOXMLDOC01-appb-C000003
Figure JPOXMLDOC01-appb-C000003
を挙げることができる。重合性ビニル単量体として、好ましくは、(1)および(2)からなる群から選択される少なくとも1種の化合物と(3) からなる群から選択される少なくとも1種の化合物とを組み合わせて使用される。特に好ましくは、アクリル酸またはメタクリル酸とメチルメタクリレートとの組み合わせ使用である。 Can be mentioned. The polymerizable vinyl monomer is preferably a combination of at least one compound selected from the group consisting of (1) and (2) and at least one compound selected from the group consisting of (3). used. Particularly preferred is a combination use of acrylic acid or methacrylic acid and methyl methacrylate.
 PVA共重合体として好ましくは、前述する部分けん化PVAを骨格として、アクリル酸とメチルメタクリレートを共重合化した高分子共重合体である。かかる高分子共重合体として、具体的には、後述する実験例および実施例で使用するポバコート(POVACOAT(登録商標)Type F, Type R,およびType L(大同化成社製)を例示することができる。 The PVA copolymer is preferably a polymer copolymer obtained by copolymerizing acrylic acid and methyl methacrylate with the above-described partially saponified PVA as a skeleton. Specific examples of such polymer copolymers include POVACOAT (POVACOAT (registered trademark) Type F, Type R, and Type L (manufactured by Daido Kasei Co., Ltd.)) used in the experimental examples and examples described below. it can.
 本発明の硬質カプセル中のPVA共重合体とPVAとの配合割合は、通常PVA共重合体:PVA=100:1~1:100(重量比、以下同じ)である。好ましくは99:1~1:99、より好ましくは90:10~1:99、さらに好ましくは80:20~1:99である。また実験例2および3に示すように、PVA共重合体とPVAとの割合が50:50~1:100、好ましくは50:50~1:99である場合、カプセル調製液の粘度(52℃)が約1500Pa・s以下に、またPVA共重合体とPVAとの割合が40:60~1:100、好ましくは40:60~1:99である場合、カプセル調製液の粘度(52℃)が約1350Pa・s以下に低減し、これに伴い、硬質カプセルの生産収率(%)も90%以上に向上する。 The blending ratio of the PVA copolymer and PVA in the hard capsule of the present invention is usually PVA copolymer: PVA = 100: 1 to 1: 100 (weight ratio, hereinafter the same). The ratio is preferably 99: 1 to 1:99, more preferably 90:10 to 1:99, and still more preferably 80:20 to 1:99. Further, as shown in Experimental Examples 2 and 3, when the ratio of the PVA copolymer to PVA is 50:50 to 1: 100, preferably 50:50 to 1:99, the viscosity of the capsule preparation liquid (52 ° C. ) Is about 1500 Pa · s or less, and the ratio of PVA copolymer to PVA is 40:60 to 1: 100, preferably 40:60 to 1:99, the viscosity of the capsule preparation liquid (52 ° C.) Is reduced to about 1350 Pa · s or less, and accordingly, the production yield (%) of the hard capsule is also improved to 90% or more.
 本発明で用いる硬質カプセル(カプセルフィルム)中に含まれる上記PVA共重合体とPVA(総量)の割合は、特に制限されないが、水分を除いたカプセルフィルムの重量を100重量%とした場合、通常70~99.9重量%、好ましくは80~99.7重量%、より好ましくは90~99.5重量%の割合を挙げることができる。 The ratio of the PVA copolymer and PVA (total amount) contained in the hard capsule (capsule film) used in the present invention is not particularly limited, but when the weight of the capsule film excluding moisture is 100% by weight, The ratio can be 70 to 99.9% by weight, preferably 80 to 99.7% by weight, and more preferably 90 to 99.5% by weight.
 本発明の硬質カプセル(カプセルフィルム)には、上記PVA共重合体およびPVAに加えて、有機酸およびその塩からなる群から選択される少なくとも1種を配合することもできる。ここで有機酸塩としては、制限されないが、酢酸、酒石酸、乳酸、リンゴ酸、琥珀酸および蓚酸などの可食性の有機酸またはそれらのアルカリ金属塩、特にナトリウム塩およびカリウム塩を挙げることができる。好ましくは、酢酸および酒石酸またはこれらのナトリウム塩およびカリウム塩であり、より好ましくは酢酸ナトリウムおよび酒石酸ナトリウムである。なお、これらは一種単独で使用してもよいし、また二種以上を任意に組み合わせて使用することもできる。 In the hard capsule (capsule film) of the present invention, in addition to the PVA copolymer and PVA, at least one selected from the group consisting of organic acids and salts thereof may be blended. Examples of the organic acid salt include, but are not limited to, edible organic acids such as acetic acid, tartaric acid, lactic acid, malic acid, succinic acid and succinic acid, or alkali metal salts thereof, particularly sodium salt and potassium salt. . Acetic acid and tartaric acid or sodium and potassium salts thereof are preferred, and sodium acetate and sodium tartrate are more preferred. These may be used alone or in any combination of two or more.
 これらの有機酸および/またはその塩は、制限されないが、通常、硬質カプセル中に含まれるPVA共重合体とPVAならびに有機酸および/またはその塩の総量100重量%中に、有機酸および/またはその塩(総量)が、有機酸の割合に換算して、0.1~19重量%、好ましくは0.15~8重量%含まれるような割合で使用される。より好ましくは0.2~3重量%、特に好ましくは0.5~1重量%の割合である。 These organic acids and / or salts thereof are not limited, but usually, the organic acid and / or PVA copolymer and PVA contained in the hard capsule and the organic acid and / or salt thereof in a total amount of 100% by weight. The salt (total amount) is used in such a proportion that it is contained in an amount of 0.1 to 19% by weight, preferably 0.15 to 8% by weight in terms of the proportion of the organic acid. The proportion is more preferably 0.2 to 3% by weight, particularly preferably 0.5 to 1% by weight.
 また本発明で用いる硬質カプセル(カプセルフィルム)には、上記成分に加えて、ゲル化剤を配合することもできる。ここで用いられるゲル化剤としては、カラギーナン、タマリンド種子多糖、ペクチン、キサンタンガム、ローカストビーンガム、カードラン、ゼラチン、ファーセレラン、寒天、およびジェランガムなどを例示することができる。これらは1種単独で使用しても、2種以上を任意に組み合わせて使用することもできる。 In addition to the above components, a gelling agent can also be blended in the hard capsule (capsule film) used in the present invention. Examples of the gelling agent used here include carrageenan, tamarind seed polysaccharide, pectin, xanthan gum, locust bean gum, curdlan, gelatin, fur celerane, agar, and gellan gum. These may be used alone or in any combination of two or more.
 上記ゲル化剤のなかでもカラギーナンは、ゲル強度が高く、しかも特定イオンとの共存下で少量の使用で優れたゲル化性を示すことから最適なゲル化剤である。なお、カラギーナンには、一般にカッパ-カラギーナン、イオタ-カラギーナンおよびラムダ-カラギーナンの3種が知られている。本発明では、ゲル化能を有するカッパおよびイオタ-カラギーナンを好適に使用することができる。またペクチンはエステル化度の違いでLMペクチンとHMペクチンとに分類でき、ジェランガムもアシル化の有無によってアシル化ジェランガム(ネイティブジェランガム)と脱アシル化ジェランガムに分類することができるが、本発明ではいずれも区別することなく使用することができる。 Among the above gelling agents, carrageenan is an optimal gelling agent because of its high gel strength and excellent gelling properties when used in a small amount in the presence of specific ions. In general, three types of carrageenan are known: kappa-carrageenan, iota-carrageenan, and lambda-carrageenan. In the present invention, kappa and iota-carrageenan having gelling ability can be preferably used. Pectin can be classified into LM pectin and HM pectin depending on the degree of esterification, and gellan gum can be classified into acylated gellan gum (native gellan gum) and deacylated gellan gum according to the presence or absence of acylation. Can also be used without distinction.
 本発明の硬質カプセル(カプセルフィルム)には、使用するゲル化剤の種類に応じてゲル化補助剤を使用することもできる。ゲル化剤としてカラギーナンを使用する場合に組み合わせて用いることができるゲル化補助剤としては、カッパ-カラギーナンについては水中でカリウムイオン、アンモニウムイオンおよびカルシウムイオンの1種又は2種以上を与えることのできる化合物、例えば塩化カリウム、リン酸カリウム、塩化アンモニウム、酢酸アンモニウム、塩化カルシウムを挙げることができる。またイオタ-カラギーナンについては水中でカルシウムイオンを与えることのできる、例えば塩化カルシウムを挙げることができる。またゲル化剤としてジェランガムを使用する場合に組み合わせて用いることができるゲル化補助剤としては、水中でナトリウムイオン、カリウムイオン、カルシウムイオンおよびマグネシウムイオンの1種又は2種以上を与えることのできる化合物、例えば塩化ナトリウム、塩化カリウム、塩化カルシウム、硫酸マグネシウムを挙げることができる。 In the hard capsule (capsule film) of the present invention, a gelling aid can be used depending on the type of gelling agent used. As a gelling aid that can be used in combination when carrageenan is used as a gelling agent, kappa-carrageenan can give one or more of potassium ion, ammonium ion and calcium ion in water. There may be mentioned compounds such as potassium chloride, potassium phosphate, ammonium chloride, ammonium acetate, calcium chloride. As for iota-carrageenan, calcium ion can be given in water, for example, calcium chloride. Moreover, as a gelling adjuvant that can be used in combination when gellan gum is used as a gelling agent, a compound that can give one or more of sodium ions, potassium ions, calcium ions, and magnesium ions in water. Examples include sodium chloride, potassium chloride, calcium chloride, and magnesium sulfate.
 併用するゲル化剤として、好ましくは、カラギーナン、タマリンド種子多糖、キサンタンガム、ローカストビーンガム、およびジェランガムであり、特に好ましくはカラギーナンである。またこれを併用するゲル化補助剤としては、塩化カリウムを好適に例示することができる。 As the gelling agent used in combination, carrageenan, tamarind seed polysaccharide, xanthan gum, locust bean gum, and gellan gum are preferable, and carrageenan is particularly preferable. Moreover, potassium chloride can be illustrated suitably as a gelatinization adjuvant which uses this together.
 なお、本発明で用いる硬質カプセル(カプセルフィルム)が上記ゲル化剤を含む場合、その含有量としては、水分を除いたカプセルフィルムの重量を100重量%とした場合、0.05~10重量%、好ましくは0.1~5重量%、より好ましくは0.2~2.5重量%、さらに好ましくは0.3~2重量%を挙げることができる。さらに塩化カリウムなどのゲル化補助剤を含む場合、その含有量として2.2重量%以下の範囲、好ましくは0.1~1.5重量%、より好ましくは0.2~1重量%、さらに好ましくは0.3~0.8重量%を挙げることができる。 When the hard capsule (capsule film) used in the present invention contains the gelling agent, the content is 0.05 to 10% by weight when the weight of the capsule film excluding moisture is 100% by weight. Preferably, 0.1 to 5% by weight, more preferably 0.2 to 2.5% by weight, and still more preferably 0.3 to 2% by weight. Further, when a gelling aid such as potassium chloride is included, the content thereof is in the range of 2.2% by weight or less, preferably 0.1 to 1.5% by weight, more preferably 0.2 to 1% by weight, Preferably, 0.3 to 0.8% by weight can be mentioned.
 なお、硬質カプセル(カプセルフィルム)には、上記成分(PVA共重合体およびポリビニルアルコール、必要に応じて有機酸および/またはその塩、およびゲル化剤やゲル化補助剤)に加えて、必要に応じて、可塑剤、金属封鎖剤、不透明化剤、着色料または香料などを配合することもできる。 In addition to the above components (PVA copolymer and polyvinyl alcohol, if necessary, organic acid and / or salt thereof, and gelling agent or gelling aid), the hard capsule (capsule film) needs Depending on the case, a plasticizer, a metal sequestering agent, an opacifying agent, a coloring agent or a fragrance can be blended.
 ここで可塑剤としては、医薬品または食品に使用できるものであれば特に制限されないが、例えば、アジピン酸ジオクチル,アジピン酸ポリエステル,エポキシ化ダイズ油,エポキシヘキサヒドロフタル酸ジエステル,カオリン,クエン酸トリエチル,グリセリン,グリセリン脂肪酸エステル,ゴマ油,ジメチルポリシロキサン・二酸化ケイ素混合物,D-ソルビトール,中鎖脂肪酸トリグリセリド,トウモロコシデンプン由来糖アルコール液,トリアセチン,濃グリセリン,ヒマシ油,フィトステロール,フタル酸ジエチル,フタル酸ジオクチル,フタル酸ジブチル,ブチルフタリルブチルグリコレート,プロピレングリコール,ポリオキシエチレン(105)ポリオキシプロピレン(5)グリコール,ポリソルベート80,ポリエチレングリコール1500,ポリエチレングリコール400,ポリエチレングリコール4000,ポリエチレングリコール600,ポリエチレングリコール6000,ミリスチン酸イソプロピル,綿実油・ダイズ油混合物,モノステアリン酸グリセリン,リノール酸イソプロピルなどを挙げることができる。なお、可塑剤を用いる場合、本発明で用いる硬質カプセル(カプセルフィルム)中の含有量として、水分を除いたカプセルフィルムの重量を100重量%とした場合、通常15重量%以下の範囲を挙げることができる。好ましくは13重量%以下、より好ましくは11重量%以下、さらに好ましくは8重量%以下の範囲である。 Here, the plasticizer is not particularly limited as long as it can be used for pharmaceuticals or foods. For example, dioctyl adipate, polyester adipate, epoxidized soybean oil, epoxyhexahydrophthalic acid diester, kaolin, triethyl citrate, Glycerin, glycerin fatty acid ester, sesame oil, dimethylpolysiloxane / silicon dioxide mixture, D-sorbitol, medium chain fatty acid triglyceride, corn starch-derived sugar alcohol solution, triacetin, concentrated glycerin, castor oil, phytosterol, diethyl phthalate, dioctyl phthalate, Dibutyl phthalate, butyl phthalyl butyl glycolate, propylene glycol, polyoxyethylene (105) polyoxypropylene (5) glycol, polysorbate 80, polyethylene Recall 1500, polyethylene glycol 400, polyethylene glycol 4000, polyethylene glycol 600, polyethylene glycol 6000, isopropyl myristate, cottonseed oil, soybean oil mixture, glyceryl monostearate, and the like linoleic acid isopropyl. When a plasticizer is used, the content in the hard capsule (capsule film) used in the present invention is usually 15% by weight or less when the weight of the capsule film excluding moisture is 100% by weight. Can do. Preferably it is 13 weight% or less, More preferably, it is 11 weight% or less, More preferably, it is the range of 8 weight% or less.
 金属封鎖剤としては、エチレンジアミン四酢酸、酢酸、ホウ酸、クエン酸、グルコン酸、乳酸、リン酸、酒石酸、またはこれらの塩、メタホスフェート、ジヒドロキシエチルグリシン、レシチン、β-シクロデキストリン、またはこれらの組み合わせを挙げることができる。 As a sequestering agent, ethylenediaminetetraacetic acid, acetic acid, boric acid, citric acid, gluconic acid, lactic acid, phosphoric acid, tartaric acid, or salts thereof, metaphosphate, dihydroxyethylglycine, lecithin, β-cyclodextrin, or these Combinations can be mentioned.
 また不透明化剤および香料としては、医薬品または食品に使用できるものであれば特に制限されない。 Further, the opacifying agent and the fragrance are not particularly limited as long as they can be used for pharmaceuticals or foods.
 本発明で用いる硬質カプセルは、定法の浸漬法を利用して製造することができる、具体的には前述する成分を含有する水溶液(ここでは、以下「カプセル調製液」という)を浸漬液とし、これにカプセル成型用ピンを浸漬し、次いで引き上げてカプセル成型用ピンの外表面に形成されたカプセル調製液からなる皮膜を冷却してゲル化させ、次いで乾燥させる工程を経て製造することができる。 The hard capsule used in the present invention can be produced by using a conventional dipping method. Specifically, an aqueous solution containing the above-described components (hereinafter referred to as “capsule preparation solution”) is used as the dipping solution. The capsule molding pin can be immersed in this, and then pulled up to cool and gel the film made of the capsule preparation liquid formed on the outer surface of the capsule molding pin, and then dried.
 カプセル調製液中に含まれる上記各成分の濃度は、前述するカプセルフィルム中の各成分の割合に従って適宜調整することができる。具体的には、PVA共重合体とPVAの総量については、5~30重量%、好ましくは10~28重量%、より好ましくは16~24重量%を挙げることができる。また有機酸および/またはその塩については、有機酸の割合に換算して、0.02~3.8重量%、好ましくは0.04~1.6重量%、より好ましくは0.04~0.2重量%を挙げることができる。 The concentration of each component contained in the capsule preparation liquid can be appropriately adjusted according to the ratio of each component in the capsule film described above. Specifically, the total amount of the PVA copolymer and PVA can be 5 to 30% by weight, preferably 10 to 28% by weight, more preferably 16 to 24% by weight. The organic acid and / or salt thereof is 0.02 to 3.8% by weight, preferably 0.04 to 1.6% by weight, more preferably 0.04 to 0% in terms of the ratio of the organic acid. 2% by weight can be mentioned.
 またゲル化剤を用いる場合、そのカプセル調製液中の濃度として0.01~2重量%、好ましくは0.02~1重量%、より好ましくは0.03~0.5重量%を挙げることができる。また、ゲル化補助剤を用いる場合は、そのカプセル調製液中の濃度として0.01~0.5重量%、好ましくは0.02~0.3重量%、より好ましくは0.03~0.2重量%を挙げることができる。 When a gelling agent is used, the concentration in the capsule preparation liquid is 0.01 to 2% by weight, preferably 0.02 to 1% by weight, more preferably 0.03 to 0.5% by weight. it can. When a gelling aid is used, the concentration in the capsule preparation liquid is 0.01 to 0.5% by weight, preferably 0.02 to 0.3% by weight, more preferably 0.03 to 0.3%. 2% by weight can be mentioned.
 カプセル調製液中に含まれる溶媒(水)の量は、制限されないが、カプセル成型用ピンの浸漬時に採用される温度(浸漬液の温度)条件下(30~80℃、好ましくは40~60℃)で、カプセル調製液の粘度が100~20000mPa・s、好ましくは300~10000mPa・sとなるような割合を挙げることができる。好ましくは、52℃の温度条件でのカプセル調製液の粘度が300~3600mPa・s、より好ましくは500~3100mPa・s、さらに好ましくは500~2600mPa・s、よりさらに好ましくは500~2000mPa・s、特に好ましくは500~1500mPa・sとなるような割合である。 The amount of the solvent (water) contained in the capsule preparation liquid is not limited, but is a temperature (immersion liquid temperature) condition (30 to 80 ° C., preferably 40 to 60 ° C.) employed when the capsule molding pin is immersed. ), The ratio of the viscosity of the capsule preparation liquid is 100 to 20000 mPa · s, preferably 300 to 10000 mPa · s. Preferably, the viscosity of the capsule preparation liquid at a temperature condition of 52 ° C. is 300 to 3600 mPa · s, more preferably 500 to 3100 mPa · s, still more preferably 500 to 2600 mPa · s, and still more preferably 500 to 2000 mPa · s. The ratio is particularly preferably 500 to 1500 mPa · s.
 なお、本発明で規定する粘度は、B型回転粘度計で、粘度500mPa・s未満の場合はローター番号2、粘度500mPa・s以上2000mPa・s未満の場合はローター番号3、粘度2000mPa・s以上の場合はローター番号4を用いて、所定温度で、回転数60rpm、測定時間1分の条件で測定した場合の粘度を意味する(以下、同じ)。 The viscosity specified in the present invention is a B-type rotational viscometer. When the viscosity is less than 500 mPa · s, the rotor number is 2, and when the viscosity is 500 mPa · s or more and less than 2000 mPa · s, the rotor number is 3 and the viscosity is 2000 mPa · s or more. In the case of (4), the viscosity is measured when the rotor number 4 is used and measured at a predetermined temperature under the conditions of a rotation speed of 60 rpm and a measurement time of 1 minute (hereinafter the same).
 通常、溶媒含有量として60~90重量%、好ましくは70~85重量%を挙げることができる。 Usually, the solvent content is 60 to 90% by weight, preferably 70 to 85% by weight.
 カプセル調製液(浸漬液)の調製において、上記各成分の溶解順序に制限はなく、上記必須成分(PVAおよびPVA共重合体)を先に溶解しても、またゲル化剤およびゲル化補助剤を先に溶解しても、さらにこれらを同時に溶解してもよい。また溶解温度も、通常60℃以上とすることが各成分の溶解性などから好ましいが、特に制限されるものではない。カプセル調製液は、減圧脱泡、超音波脱泡、あるいは静置により微細な泡を取り除き、50~60℃に保温した状態で、浸漬法によるカプセル成型に供することが好ましい。 In the preparation of the capsule preparation liquid (immersion liquid), the dissolution order of the above-mentioned components is not limited, and the gelling agent and the gelling auxiliary agent may be prepared by dissolving the essential components (PVA and PVA copolymer) first. Or may be dissolved simultaneously. Moreover, although it is preferable from the solubility of each component that the melting temperature is usually 60 ° C. or higher, it is not particularly limited. The capsule preparation liquid is preferably subjected to capsule molding by the dipping method in a state where fine bubbles are removed by vacuum degassing, ultrasonic defoaming or standing, and the temperature is kept at 50 to 60 ° C.
 本発明の硬質カプセルは、かくして調製されるカプセル調製液(浸漬液)にカプセル成型用ピンを浸漬した後、これを引き上げ、カプセル成型用ピンに付着した溶液をゲル化させ、その後、ゲル化した皮膜を20~80℃程度の温度で乾燥することによって製造される。具体的には、本発明で用いる硬質カプセルは下記の工程を経て製造することができる。 The hard capsule of the present invention was soaked in the capsule preparation liquid (immersion liquid) thus prepared, and then pulled up to gel the solution adhering to the capsule molding pin, and then gelled. The film is produced by drying at a temperature of about 20 to 80 ° C. Specifically, the hard capsule used in the present invention can be produced through the following steps.
 (1)PVA共重合体とPVA(また必要に応じて、有機酸および/またはその塩、またはゲル化剤やゲル化補助剤)を含有するカプセル調製液(浸漬液)に、カプセル成型用ピンを浸漬する工程(浸漬工程)、
(2)カプセル調製液(浸漬液)からカプセル成型用ピンを引き上げて、当該ピンの外表面に付着したカプセル調製液をゲル化する工程(ゲル化工程)、
(3)カプセル成型用ピンの外表面に被覆形成されたゲル化カプセルフィルム(ゲル化皮膜)を乾燥する工程(乾燥工程)、
(4)乾燥したカプセルフィルム(皮膜)をカプセル成型用ピンから脱離する工程(脱離工程)。
(1) Capsule molding pin in a capsule preparation liquid (immersion liquid) containing a PVA copolymer and PVA (or an organic acid and / or a salt thereof, or a gelling agent or a gelling aid, if necessary) The step of immersing (immersion step),
(2) A step of pulling up the capsule molding pin from the capsule preparation solution (immersion solution) to gel the capsule preparation solution adhering to the outer surface of the pin (gelation step),
(3) A step of drying the gelled capsule film (gelated film) formed on the outer surface of the capsule molding pin (drying step),
(4) A step of detaching the dried capsule film (film) from the capsule molding pin (detachment step).
 なお、上記の(2)ゲル化工程は、用いるゲル化剤の特性に応じて加熱または冷却することによって行うことができる。例えば、カプセル調製液(浸漬液)として、ゲル化剤としてカラギーナンを配合した溶液を用いる場合は、当該溶液が50℃以下の温度でゲル化することを利用して、カプセル製造機周辺の温度を通常35℃以下、好ましくは30℃以下、好ましくは室温下に設定して、上記ゲル化工程(2)をカプセル成型用ピンの外表面に付着したカプセル調製溶液を放冷することによって行うことができる(冷ゲル法)。具体的には、浸漬工程(1)において、35~60℃、好ましくは40~60℃の一定温度に調整したカプセル調製溶液(浸漬液)に、その液温に応じて10~30℃、好ましくは13~28℃、より好ましくは15~25℃に調整したカプセル成型用ピンを浸漬し、次いでゲル化工程(2)において、カプセル調製溶液(浸漬液)からカプセル成型用ピンを引き上げて、当該ピンの外表面に付着したカプセル調製溶液をゲル化する。 In addition, said (2) gelatinization process can be performed by heating or cooling according to the characteristic of the gelatinizer to be used. For example, when a solution containing carrageenan as a gelling agent is used as a capsule preparation liquid (immersion liquid), the temperature around the capsule manufacturing machine is adjusted by utilizing that the solution gels at a temperature of 50 ° C. or less. Usually, the gelation step (2) is carried out by allowing the capsule preparation solution adhering to the outer surface of the capsule molding pin to stand to cool at 35 ° C. or lower, preferably 30 ° C. or lower, preferably at room temperature. Yes (cold gel method). Specifically, in the dipping step (1), the capsule preparation solution (immersion liquid) adjusted to a constant temperature of 35 to 60 ° C., preferably 40 to 60 ° C., is preferably 10 to 30 ° C., preferably according to the liquid temperature. Is immersed in a capsule molding pin adjusted to 13 to 28 ° C., more preferably 15 to 25 ° C., and then in the gelation step (2), the capsule molding pin is pulled up from the capsule preparation solution (immersion liquid) The capsule preparation solution attached to the outer surface of the pin is gelled.
 乾燥工程(3)は20~80℃程度の温度で行うことができる。好ましくは60℃の空気を送風することによって行なわれる。脱離工程(4)は、カプセル成型用ピン表面に形成された乾燥カプセルフィルムをカプセル成型用ピンから抜き出すことによって行われる。 The drying step (3) can be performed at a temperature of about 20 to 80 ° C. Preferably, it is performed by blowing air at 60 ° C. The detachment step (4) is performed by extracting the dry capsule film formed on the surface of the capsule molding pin from the capsule molding pin.
 斯くして調製されるカプセルフィルムは、所定の長さに切断調整された後、ボディ部とキャップ部を一対に嵌合した状態または嵌合しない状態で、硬質カプセルとして提供することができる。また、予め食用油等を剥離剤として成型ピンに塗布しておくことにより、得られたカプセル(ボディ部とキャップ部)の離型性が向上して、得られた硬質カプセルの剥離回収を容易することができる。 The capsule film thus prepared can be provided as a hard capsule in a state where the body part and the cap part are fitted together or not fitted after being cut and adjusted to a predetermined length. In addition, by applying edible oil or the like as a release agent to the molding pin in advance, the release properties of the obtained capsule (body part and cap part) are improved, and the obtained hard capsule can be easily peeled and collected. can do.
 斯くして得られる本発明の硬質カプセルは、PVAとPVA共重合体とを併用しないで調製した硬質カプセルに比して破断伸びが大きいことを特徴とする。硬質カプセルとして、通常5~20mmの範囲の破断伸びが要求されるが、かかる破断伸びは最大応力が70~130Nの範囲で、大きければ大きいほど望ましい。好ましくは8~20mm、より好ましくは8.5~20mmであり、さらに好ましくは9~20mmであり、よりさらに好ましくは9.5~20mmである。また最大応力は、上記範囲であれば特に制限されないが、好ましくは75~130N、より好ましくは80~130Nである。 The hard capsule of the present invention thus obtained is characterized by having a large elongation at break as compared with a hard capsule prepared without using PVA and a PVA copolymer in combination. As a hard capsule, a breaking elongation in the range of 5 to 20 mm is usually required, and the breaking elongation is preferably as large as possible with a maximum stress in the range of 70 to 130 N. The thickness is preferably 8 to 20 mm, more preferably 8.5 to 20 mm, still more preferably 9 to 20 mm, and still more preferably 9.5 to 20 mm. The maximum stress is not particularly limited as long as it is within the above range, but is preferably 75 to 130N, more preferably 80 to 130N.
 なお、本発明において最大応力(N)および破断伸び(mm)は、オートグラフAGS-J(島津製作所製)を用いて、引張速度150mm/min、チャック間距離20mm、引張距離20mm、23℃、相対湿度40%の環境下で行う、引張試験によって求めることができる。最大応力は、かかる方法で測定される応力の最大値を意味し、また破断伸びは最大応力の1/3における引張ストロークを意味する(図1参照)。 In the present invention, the maximum stress (N) and elongation at break (mm) were measured using an autograph AGS-J (manufactured by Shimadzu Corporation), a tensile speed of 150 mm / min, a distance between chucks of 20 mm, a tensile distance of 20 mm, 23 ° C. It can be determined by a tensile test performed in an environment with a relative humidity of 40%. The maximum stress means the maximum value of the stress measured by such a method, and the elongation at break means the tensile stroke at 1/3 of the maximum stress (see FIG. 1).
 本発明で規定する硬質カプセル(カプセルフィルム)の最大応力および破断伸びは、対象カプセル(カプセルフィルム)を、60℃で2時間乾燥後、23℃で相対湿度40%の環境下で1週間保存した後に、上記条件(オートグラフAGS-J(島津製作所製)を用いて、引張速度150mm/min、チャック間距離20mm、引張距離20mm、23℃、相対湿度40%の環境下)で引張試験を行って得られる値である。 Regarding the maximum stress and elongation at break of the hard capsule (capsule film) defined in the present invention, the target capsule (capsule film) was dried at 60 ° C. for 2 hours and then stored at 23 ° C. in an environment of 40% relative humidity for 1 week. Later, a tensile test was performed using the above conditions (Autograph AGS-J (manufactured by Shimadzu Corporation) under the environment of a tensile speed of 150 mm / min, a distance between chucks of 20 mm, a tensile distance of 20 mm, 23 ° C., and a relative humidity of 40%). Is the value obtained.
 II.硬質カプセル剤およびその調製方法
 斯くして調製される硬質カプセルのボディ部とキャップ部は、前述する内容物をボディ部に充填したのち、該ボディ部にキャップ部を被覆して両者を嵌合させることにより硬質カプセル剤として提供することができる。
II. Hard capsule and its preparation method The body part and the cap part of the hard capsule thus prepared are filled with the above-mentioned contents, and then the body part is covered with the cap part to fit them together. Can be provided as a hard capsule.
 なお本発明の硬質カプセル剤には、上記で調製された硬質カプセルのボディ部とキャップ部の嵌合部に、バンドシールを付したものも含まれる。かかる硬質カプセル剤は、上記ボディ部とキャップ部を嵌合・接合させた後、キャップ部の端縁部を中心として、それを跨ぐように一定幅でボディ部の表面とキャップ部の表面に、その円周方向に、バンドシール調製液を1回~複数回、好ましくは1~2回塗布して嵌合部を封緘することによって、調製することができる。 The hard capsule of the present invention includes those obtained by attaching a band seal to the fitting part of the body part and the cap part of the hard capsule prepared above. Such a hard capsule, after fitting and joining the body part and the cap part, around the end edge part of the cap part, on the surface of the body part and the surface of the cap part with a constant width so as to straddle it, It can be prepared by applying the band seal preparation solution once to a plurality of times, preferably once or twice in the circumferential direction and sealing the fitting portion.
 硬質カプセルのボディ部とキャップ部の両者を嵌合させる際に、ボディ部の外周とキャップ部の内周とが重なっている嵌合巾はカプセルの軸線方向の距離で、3号カプセルについては約4.5~6.5mm、4号カプセルについては約4~6mmが一般的に好ましい。また、封緘(シール)巾は、3号カプセルで約1.5~3mm、4号カプセルで約1.5~2.8mmが一般的に好ましい。 When fitting both the body part and the cap part of the hard capsule, the fitting width where the outer circumference of the body part and the inner circumference of the cap part overlap is the distance in the axial direction of the capsule. About 4 to 6 mm is generally preferred for 4.5-6.5 mm, No. 4 capsules. The sealing width is generally about 1.5 to 3 mm for the No. 3 capsule and about 1.5 to 2.8 mm for the No. 4 capsule.
 本発明の硬質カプセル剤のバンドシール形成には、少なくともバンドシール性を有するものであれば制限はされないが、好ましくはPVA共重合体、PVA、または前述する硬質カプセルと同様の組成からなるPVA共重合体とPVA(また、必要に応じて有機酸および/またはその塩、またはゲル化剤やゲル化補助剤を併用)を含有するバンドシール調製液が使用される。 The band seal formation of the hard capsule of the present invention is not limited as long as it has at least band sealability, but preferably PVA copolymer, PVA, or PVA copolymer having the same composition as the hard capsule described above. A band seal preparation solution containing a polymer and PVA (also used in combination with an organic acid and / or a salt thereof, or a gelling agent or a gelling aid as required) is used.
 またかかるバンドシール調製液には、上記のPVA共重合体、PVAまたはこれらの混合物の他に、可塑剤としてソルビトールを配合することもできる。かかる可塑剤(ソルビトール)を配合することによって、柔軟性の増加という効果を得ることができる。バンドシール中のソルビトールの配合割合としては、PVAまたは/PVA共重合体のバンドシール性を損なわない範囲であれば特に制限されないものの、上記効果の点から、バンドシール(乾燥重量換算:100重量%)中の濃度として0.01~70重量%、好ましくは0.01~35重量%、より好ましくは0.01~30重量%、特に好ましくは1~30重量%を挙げることができる。 In addition to the PVA copolymer, PVA or a mixture thereof, sorbitol can also be blended in the band seal preparation liquid as a plasticizer. By blending such a plasticizer (sorbitol), an effect of increasing flexibility can be obtained. The blending ratio of sorbitol in the band seal is not particularly limited as long as it does not impair the band sealability of the PVA or / PVA copolymer, but in terms of the above effects, the band seal (in terms of dry weight: 100% by weight) ) In the range of 0.01 to 70% by weight, preferably 0.01 to 35% by weight, more preferably 0.01 to 30% by weight, and particularly preferably 1 to 30% by weight.
 なお、本発明において「バンドシール性」とは、硬質カプセルのボディ部とキャップ部を封緘(シール)するためのフィルムを形成することができ(フィルム形成能)、且つ、このフィルムによる封緘によってボディ部とキャップ部との嵌合部から内容物が漏出することを防止し得る(漏出防止能)、バンドシールの性質を意味する。 In the present invention, “band sealability” means that a film for sealing (sealing) the body part and the cap part of a hard capsule can be formed (film forming ability), and the body is sealed by sealing with this film. It means the property of the band seal that can prevent the contents from leaking out from the fitting portion between the cap portion and the cap portion (leakage prevention capability).
 当該「バンドシール性」の有無は、対象とするバンドシール調製液を用いて、平均分子量400のポリエチレングリコール(PEG400)を充填したカプセルのキャップ部とボディ部の嵌合部を封緘(バンドシール)し、これを25℃、相対湿度40%の環境下に白色コピー用紙の上に12時間放置した場合に、バンドシール部から内容物の漏出があるか否かで評価することができる。 The presence or absence of the “band sealability” is determined by sealing the cap part of the capsule filled with polyethylene glycol (PEG400) with an average molecular weight of 400 (PEG400) and the fitting part of the body part using the target band seal preparation solution (band seal) When this is left on a white copy paper for 12 hours in an environment of 25 ° C. and a relative humidity of 40%, it can be evaluated by whether or not the contents leak from the band seal portion.
 なお、内容物の漏出の有無は、実験例5に示すように、下記の基準から判断することができる:
(a)12時間放置後、封緘硬質カプセル剤と接していた白色コピー用紙面に、内容物(PEG400)が付着しているか否か。
(b)12時間放置後、封緘硬質カプセル剤を白色コピー用紙上で転がしたときに、白色コピー用紙面に内容物(PEG400)が付着するか否か。
In addition, the presence or absence of leakage of the contents can be determined from the following criteria as shown in Experimental Example 5:
(a) Whether the contents (PEG400) are attached to the surface of the white copy paper that has been in contact with the sealed hard capsule after standing for 12 hours.
(b) Whether the contents (PEG400) adhere to the white copy paper surface when the sealed hard capsule is rolled on the white copy paper after being left for 12 hours.
 この場合、(a)と(b)のいずれの場合も、白色コピー用紙への内容物の付着がない、すなわち内容物の漏出が認められない場合を「バンドシール性あり」、(a)と(b)のいずれかの場合で内容物の漏出が認められる場合を「バンドシール性なし」と判断することができる。 In this case, in both cases (a) and (b), the case where there is no adhesion of the content to the white copy paper, that is, no leakage of the content is recognized, is `` with band sealability '', (a) In any of the cases (b), it can be determined that there is no band-sealability when content leakage is observed.
 なお、当該バンドシール性の評価試験に使用するカプセルとしては、後述する実験例5に記載するPVA共重合体を基材とする硬質カプセルまたはPVAを基材とする硬質カプセルを挙げることができる。また中に充填するPEG400の量としては、硬質カプセルが日本薬局方で定めるサイズ0号のカプセルの場合は600μL、サイズ1号のカプセルの場合は470μLを挙げることができる。 In addition, as a capsule used for the said band seal property evaluation test, the hard capsule which uses the PVA copolymer as a base material described in Experimental Example 5 mentioned later, or the hard capsule which uses PVA as a base material can be mentioned. The amount of PEG 400 filled therein may be 600 μL when the hard capsule is a size 0 capsule defined by the Japanese Pharmacopoeia, and 470 μL when the hard capsule is a size 1 capsule.
 さらに、バンドシールには、本発明の効果、すなわちバンドシール性を妨げないことを限度として、上記成分に加えて、任意に着色剤(例えば、酸化チタン、ベンガラ、タール系色素など)、不透明化剤、または香料など、硬質カプセルの調製に通常使用される添加剤を配合することもできる。バンドシールに対するこれらの添加剤の配合割合は、通常0.1~7重量%の範囲からバンドシール性を考慮して適宜選択することができる。 In addition to the above components, the band seal is optionally colored (for example, titanium oxide, bengara, tar colorant, etc.), opaque, as long as the effect of the present invention, ie, the band sealability is not hindered. Additives usually used in the preparation of hard capsules such as agents or fragrances can also be blended. The blending ratio of these additives to the band seal can be appropriately selected from the range of usually 0.1 to 7% by weight in consideration of the band sealing property.
 硬質カプセル剤においてバンドシールを形成するにあたっては、通常バンドシール調製液が使用される。当該バンドシールの調製液は、上記のバンドシール成分を、水、親水性溶媒または水と親水性溶媒との混合液に、室温または加温下(約30~60℃)で溶解することによって調製することができる。好ましくは水と親水性溶媒との混合液が使用される。ここで親水性溶媒としては、水と相溶性のある有機溶媒を挙げることができ、具体的には、エタノール、イソプロパノールなどの低級アルコールを挙げることができる。好ましくはエタノールである。バンドシール調製液の調製に水と親水性溶媒との混合液を用いる場合、当該混合液100重量%中の親水性溶媒の割合として5~80重量%、好ましくは8~65重量%、より好ましくは10~50重量%を挙げることができる。 When forming a band seal in a hard capsule, a band seal preparation solution is usually used. The band seal preparation solution is prepared by dissolving the above band seal component in water, a hydrophilic solvent, or a mixture of water and a hydrophilic solvent at room temperature or under heating (about 30 to 60 ° C.). can do. Preferably, a mixed solution of water and a hydrophilic solvent is used. Here, examples of the hydrophilic solvent include organic solvents compatible with water, and specific examples include lower alcohols such as ethanol and isopropanol. Ethanol is preferable. When a mixed liquid of water and a hydrophilic solvent is used for preparing the band seal preparation liquid, the ratio of the hydrophilic solvent in 100% by weight of the mixed liquid is 5 to 80% by weight, preferably 8 to 65% by weight, more preferably May be 10 to 50% by weight.
 バンドシール調製液は、調製液の最終粘度が通常23℃条件下、100~5000mPa・sの範囲になるように調整される。なお、当該粘度は、B型回転粘度計で、粘度500mPa・s未満の場合はローター番号2、粘度500mPa・s以上2000mPa・s未満の場合はローター番号3、粘度2000mPa・s以上の場合はローター番号4を用いて、23℃、回転数60rpm、測定時間1分の条件で測定した場合の粘度を意味する。 The band seal preparation liquid is adjusted so that the final viscosity of the preparation liquid is usually in the range of 100 to 5000 mPa · s under the condition of 23 ° C. The viscosity is a B-type rotational viscometer. When the viscosity is less than 500 mPa · s, the rotor number is 2, when the viscosity is 500 mPa · s or more and less than 2000 mPa · s, the rotor number is 3, and when the viscosity is 2000 mPa · s or more, the rotor is The number 4 is used to mean the viscosity when measured under the conditions of 23 ° C., rotation speed 60 rpm, and measurement time 1 minute.
 粘度がかかる範囲にあるバンドシール調製液によれば、硬質カプセル剤のボディ部とキャップ部の嵌合部にシール力(封緘力)の大きい強固なバンドシールを形成することができ、しかも製造時における糸曳きがなく、製造における取り扱いも容易である。なお、バンドシール調製液の粘度が上記範囲(100~5000mPa・s、23℃)よりも著しく低い場合、硬質カプセル剤の嵌合部表面にバンドシール調製液を液だれしないで塗布するということが難しく、封緘力に優れたバンドシールが形成できない可能性がある。一方、バンドシール調製液の粘度が上記範囲(100~5000mPa・s、23℃)よりも著しく高い場合、粘度が高すぎて機械でバンドシールを形成できない可能性がある。バンドシール調製液の好ましい粘度は、23℃条件下、125~4700mPa・sであり、より好ましくは150~4500mPa・sである。 According to the band seal preparation liquid in the range where the viscosity is applied, a strong band seal with a large sealing force (sealing force) can be formed in the fitting part of the hard capsule body and cap part, and at the time of manufacture There is no stringing and the handling in production is easy. If the viscosity of the band seal preparation liquid is significantly lower than the above range (100 to 5000 mPa · s, 23 ° C.), the band seal preparation liquid may be applied without dripping onto the fitting surface of the hard capsule. It may be difficult to form a band seal excellent in sealing power. On the other hand, when the viscosity of the band seal preparation liquid is significantly higher than the above range (100 to 5000 mPa · s, 23 ° C.), the viscosity may be too high to form a band seal with a machine. The preferred viscosity of the band seal preparation liquid is 125 to 4700 mPa · s, more preferably 150 to 4500 mPa · s, at 23 ° C.
 なお、バンドシール調製液の粘度は、バンドシール調製液に配合するPVA共重合体、PVAまたはこれらの混合物の濃度や両者の配合比を調節することによって簡便に調整することができる。具体的には、PVA共重合体と併用するPVAの割合を増加させるにつれて、粘度は低下する傾向にある。配合するPVA共重合体やPVAの種類やその重合度によっても異なるが、バンドシール調製液中のPVAの濃度としては、通常4~31重量%、好ましくは5~30重量%、より好ましくは6~29重量%を、またPVA共重合体の濃度としては、通常5~27重量%、好ましくは6~26重量%、より好ましくは7~25重量%を挙げることができる。PVAとPVA共重合体とを併用する場合は、上記各成分の割合を基準として、粘度(100~5000mPa・s、23℃)を考慮して調整することができる。 The viscosity of the band seal preparation liquid can be easily adjusted by adjusting the concentration of the PVA copolymer, PVA or a mixture thereof mixed in the band seal preparation liquid, or the mixing ratio of both. Specifically, the viscosity tends to decrease as the proportion of PVA used in combination with the PVA copolymer is increased. The concentration of PVA in the band seal preparation liquid is usually 4 to 31% by weight, preferably 5 to 30% by weight, more preferably 6%, although it depends on the type of PVA copolymer and PVA to be blended and the degree of polymerization. The concentration of PVA copolymer is usually from 5 to 27% by weight, preferably from 6 to 26% by weight, more preferably from 7 to 25% by weight. When PVA and a PVA copolymer are used in combination, the viscosity can be adjusted in consideration of the viscosity (100 to 5000 mPa · s, 23 ° C.) on the basis of the ratio of each component.
 またバンドシールにソルビトールを配合する場合、そのバンドシール調製液中の濃度は、前述するバンドシール中のソルビトールの配合割合に沿って決定することができる。具体的には、バンドシール調製液の粘度が100~5000mPa・sの範囲になるように考慮しながら、バンドシール(100重量%)中のソルビトールの濃度が0.01~70重量%、好ましくは0.01~35重量%、より好ましくは0.01~30重量%、特に好ましくは1~30重量%となるように、バンドシール調製液を調整することが好ましい。 Further, when sorbitol is blended in the band seal, the concentration in the band seal preparation liquid can be determined according to the blending ratio of sorbitol in the band seal described above. Specifically, the sorbitol concentration in the band seal (100 wt%) is 0.01 to 70 wt%, preferably while considering that the viscosity of the band seal preparation solution is in the range of 100 to 5000 mPa · s. It is preferable to adjust the band seal preparation solution so as to be 0.01 to 35% by weight, more preferably 0.01 to 30% by weight, and particularly preferably 1 to 30% by weight.
 かかるバンドシールは、本発明の硬質カプセル内にポリエチレングリコール(PEG)またはこれを含む組成物を充填した硬質カプセル剤のバンドシールとして好適である。 Such a band seal is suitable as a band seal of a hard capsule in which the hard capsule of the present invention is filled with polyethylene glycol (PEG) or a composition containing the same.
 ここでPEGとしては、特に制限されず、およその平均分子量が20000以下のPEG、具体的には、当該平均分子量が200、300、400、600、800、1000、1500、2000、3000、4000、6000、8000または20000のPEGを挙げることができる。なお、これら各平均分子量を有するPEGは、各社メーカーから日本薬局方や医薬品添加物の規格に従って(「日本薬局方」および「医薬品添加物規格」参照のこと)「ポリエチレングリコール○○○」(ここで○○○は、上記するPEGのおよその平均分子量を示す)といった共通した表示で販売されている。かかるPEGは、1種単独でまたは2種以上を組み合わせて使用することができる。中でも、平均分子量が200~600のPEG(「PEG200~600」ともいう)などの低分子量PEGは、本発明のバンドシールの使用において硬質カプセル剤の充填成分として好適に用いられるPEGである。すなわち、本発明のバンドシールによれば、PEG200~600を充填しても滲みだしという問題がなく、本発明の効果をより効果的に享受することが可能となる。 Here, the PEG is not particularly limited, and the PEG having an average molecular weight of about 20000 or less, specifically, the average molecular weight is 200, 300, 400, 600, 800, 1000, 1500, 2000, 3000, 4000, Mention may be made of 6000, 8000 or 20000 PEG. In addition, PEG having each of these average molecular weights can be obtained from each manufacturer according to Japanese Pharmacopoeia and pharmaceutical additive standards (see “Japanese Pharmacopoeia” and “Pharmaceutical Additives Standards”). And XX indicates the approximate average molecular weight of the above-mentioned PEG). Such PEG can be used individually by 1 type or in combination of 2 or more types. Among them, low molecular weight PEG such as PEG having an average molecular weight of 200 to 600 (also referred to as “PEG 200 to 600”) is a PEG that is suitably used as a filling component of a hard capsule in the use of the band seal of the present invention. That is, according to the band seal of the present invention, there is no problem of bleeding even when PEG 200 to 600 is filled, and the effect of the present invention can be enjoyed more effectively.
 なお、PEGの平均分子量は「日本薬局方」および「医薬品添加物規格」に規定される規格に従って下記の試験に従って測定することができる。 In addition, the average molecular weight of PEG can be measured according to the following test according to the standards defined in “Japanese Pharmacopoeia” and “Pharmaceutical Additives Standard”.
 (平均分子量試験)
 無水フタル酸42gをとり、新たに蒸留したピリジン300mLを正確に量って入れた1Lの遮光した共栓瓶に加え、強く振り混ぜて溶かした後、16時間以上放置する。この液25mLを正確に量り、約200mLの耐圧共栓瓶に入れ、これに測定するPEG試料約0.8~15gを精密に量って加え、密栓し、これを丈夫な布で包み、あらかじめ98±2℃に加熱した水浴中に入れる。この際、瓶の中の液が水浴の液の中に浸るようにする。98±2℃で30分間保った後、水浴から瓶を取り出し、室温になるまで空気中で放冷する。次に0.5mol/L 水酸化ナトリウム液 50mLを正確に加え、更にフェノールフタレインのピリジン溶液(1→100)5滴を加え、この液につき、0.5mol/L 水酸化ナトリウム液で滴定する。但し、滴定の終点は液が15秒間持続する淡赤色を呈するときとする。同様の方法で空試験を行う。
(Average molecular weight test)
Take 42 g of phthalic anhydride, add to a 1 L light-shielded stoppered bottle containing exactly 300 mL of freshly distilled pyridine, stir vigorously and let stand for at least 16 hours. Weigh accurately 25 mL of this solution, put it in an approximately 200 mL pressure-resistant stopper bottle, add approximately 0.8 to 15 g of the PEG sample to be measured to it, seal tightly, wrap it in a sturdy cloth, Place in a water bath heated to 2 ° C. At this time, the liquid in the bottle is immersed in the liquid in the water bath. After maintaining at 98 ± 2 ° C for 30 minutes, remove the bottle from the water bath and let it cool in air until it reaches room temperature. Next, add exactly 50 mL of 0.5 mol / L sodium hydroxide solution, add 5 drops of pyridine solution of phenolphthalein (1 → 100), and titrate this solution with 0.5 mol / L sodium hydroxide solution. However, the end point of titration is when the liquid shows a light red color lasting 15 seconds. A blank test is performed in the same manner.
Figure JPOXMLDOC01-appb-M000004
Figure JPOXMLDOC01-appb-M000004
 かかる試験方法で試験した場合、PEG200は平均分子量が約190~210の範囲、PEG300は平均分子量が約285~315の範囲、PEG400は平均分子量が約380~420の範囲、PEG600は平均分子量が約570~630の範囲にあるとして求めることができる。 When tested by such test methods, PEG 200 has an average molecular weight in the range of about 190-210, PEG 300 has an average molecular weight in the range of about 285-315, PEG 400 has an average molecular weight in the range of about 380-420, and PEG 600 has an average molecular weight of about It can be determined as being in the range of 570 to 630.
 硬質カプセル剤の内容物は、前述するようにPEG、または少なくともPEGを含む組成物であればよく、かかる組成物としてはPEGを含むヒトまたは動物の医薬品、医薬部外品、化粧料、および食品を、制限なく挙げることができる。かかる組成物に含まれるPEGの割合は特に制限されないが、通常0.1~99.9重量%、好ましくは1~99.9重量%、より好ましくは10~99.9重量%、さらに好ましくは50~99.9重量%を挙げることができる。 The content of the hard capsule may be PEG or a composition containing at least PEG as described above, and as such a composition, human or animal pharmaceuticals, quasi drugs, cosmetics, and foods containing PEG are included. Can be mentioned without limitation. The proportion of PEG contained in such a composition is not particularly limited, but is usually 0.1 to 99.9% by weight, preferably 1 to 99.9% by weight, more preferably 10 to 99.9% by weight, still more preferably. 50 to 99.9% by weight can be mentioned.
 なお、内容物の形状も特に問わない。例えば、液状物、ゲル状物、粉末状、顆粒状、錠剤状、ペレット状、またこれらの混合形状(ハイブリッド状)であってもよい。 The shape of the contents is not particularly limited. For example, it may be a liquid, gel, powder, granule, tablet, pellet, or a mixed form (hybrid) thereof.
 硬質カプセル剤の内容物としては、医薬品の場合は、例えば滋養強壮保健薬、解熱鎮痛消炎薬、向精神薬、抗不安薬、抗うつ薬、催眠鎮静薬、鎮痙薬、中枢神経作用薬、脳代謝改善剤、脳循環改剤、抗てんかん剤、交感神経興奮剤、胃腸薬、制酸剤、抗潰瘍剤、鎮咳去痰剤、鎮吐剤、呼吸促進剤、気管支拡張剤、アレルギー用薬、歯科口腔用薬、抗ヒスタミン剤、強心剤、不整脈用剤、利尿薬。血圧降下剤、血管収縮薬、冠血管拡張剤、末梢血管拡張薬、抗高脂血症用剤、利胆剤、抗生物質、化学療法剤、糖尿病治療薬、骨粗鬆症用剤、抗リウマチ薬、骨格筋弛緩薬、鎮痙剤、ホルモン剤、アルカロイド系麻薬、サルファ剤、痛風治療薬、血液凝固阻止剤、抗悪性腫瘍剤などから選ばれる1種または2種以上の薬物成分を挙げることができる。なお、これらの薬効成分は、特に制限されず公知のものを広く挙げることができるが、具体的には、WO2006/070578号パンプレットの段落[0055]~ [0060]に記載されている各成分を例示として挙げることができる。 As the contents of hard capsules, in the case of pharmaceuticals, for example, nourishing tonics, antipyretic analgesics, antipsychotics, anxiolytics, antidepressants, hypnotic sedatives, antispasmodics, central nervous system drugs, brain Metabolic improver, cerebral circulation modifier, antiepileptic agent, sympathomimetic agent, gastrointestinal agent, antacid, antiulcer agent, antitussive expectorant, antiemetic agent, respiratory accelerator, bronchodilator, allergic agent, dental oral cavity Drugs, antihistamines, cardiotonic drugs, arrhythmia drugs, diuretics. Antihypertensive, Vasoconstrictor, Coronary vasodilator, Peripheral vasodilator, Antihyperlipidemic agent, Biliate, Antibiotic, Chemotherapeutic agent, Antidiabetic agent, Osteoporosis agent, Antirheumatic agent, Skeleton Mention may be made of one or more drug components selected from muscle relaxants, antispasmodic agents, hormone agents, alkaloid narcotics, sulfa drugs, anti-gout agents, blood coagulation inhibitors, antineoplastic agents and the like. These medicinal ingredients are not particularly limited and can include a wide range of known ingredients. Specifically, each ingredient described in paragraphs [0055] to [0060] of WO2006 / 070578 Can be given as examples.
 また、食品の場合は、例えばドコサヘキサエン酸、エイコサペンタエン酸、α-リポ酸、ローヤルゼリー、イソフラボン、アガリクス、アセロラ、アロエ、アロエベラ、ウコン、エルカルニチン、オリゴ糖、カカオ、カテキン、カプサイシン、カモミール、寒天、トコフェロール、リノレン酸、キシリトール、キトサン、GABA、クエン酸、クロレラ、グルコサミン、高麗人参、コエンザイムQ10、黒糖、コラーゲン、コンドロイチン、サルノコシカケ、スクワレン、ステビア、セラミド、タウリン、サポニン、レシチン、デキストリン、どくだみ、ナイアシン、納豆菌、にがり、乳酸菌、ノコギリヤシ、ハチミツ、はとむぎ、梅肉エキス、パントテン酸、ヒアルロン酸、ビタミンA、ビタミンK、ビタミンC、ビタミンD、ビタミンB1、ビタミンB2、ビタミンB6、ビタミンB12、ケルセチン、プロテイン、プロポリス、モロヘイヤ、葉酸、リコピン、リノール酸、ルチン、霊芝などの機能性成分などを挙げることができる。但し、これらに限定されるものではない。 In the case of food, for example, docosahexaenoic acid, eicosapentaenoic acid, α-lipoic acid, royal jelly, isoflavone, agaricus, acerola, aloe, aloe vera, turmeric, ercarnitine, oligosaccharide, cacao, catechin, capsaicin, chamomile, agar, Tocopherol, linolenic acid, xylitol, chitosan, GABA, citric acid, chlorella, glucosamine, ginseng, coenzyme Q10, brown sugar, collagen, chondroitin, sorghum, squalene, stevia, ceramide, taurine, saponin, lecithin, dextrin, dodomi, niacin, Natto, bittern, lactic acid bacteria, saw palmetto, honey, hatomugi, plum extract, pantothenic acid, hyaluronic acid, vitamin A, vitamin K, vitamin C, vitamin D, vitamin B1, bi Examples include functional components such as Tamine B2, Vitamin B6, Vitamin B12, Quercetin, Protein, Propolis, Morohaya, Folic Acid, Lycopene, Linoleic Acid, Rutin, Ganoderma. However, it is not limited to these.
 かかる内容物の硬質カプセル内への充填は、それ自体公知のカプセル充填機、例えば全自動カプセル充填機(型式名:LIQFILsuper80/150、クオリカプス社製)、カプセル充填・シール機(型式名:LIQFILsuperFS、クオリカプス社製)等を用いて実施することができる。また硬質カプセルの封緘は、それ自体公知のカプセル充填シール機、例えば前記カプセル充填・シール機またはカプセルシール機(型式名:HICAPSEAL 40/100、クオリカプス社製)等を使用して実施することができる。 Filling of the contents into the hard capsule may be performed by a capsule filling machine known per se, for example, a fully automatic capsule filling machine (model name: LIQFILsuper 80/150, manufactured by Qualicaps), a capsule filling / sealing machine (model name: LIQFILsuperFS, Qualicaps Co., Ltd.) can be used. Moreover, sealing of hard capsules can be carried out using a capsule filling and sealing machine known per se, such as the capsule filling and sealing machine or capsule sealing machine (model name: HICAPSEALSE40 / 100, manufactured by Qualicaps Co., Ltd.). .
 カプセル封緘時、バンドシール調製液は、一般に室温あるいは加温下で使用することができる。硬質カプセルの液漏れ防止という観点から、好ましくは約23~45℃、さらに好ましくは約23~35℃、最も好ましくは約25~35℃の温度範囲内にあるシール調製液を用いることが望ましい。なお、シール調製液の温度調節は、パネルヒーター、温水ヒーター等のそれ自体公知の方法で実施することができるが、例えば循環式温水ヒーターあるいは前記一体型カプセル充填シール機のシールパンユニットを循環式温水ヒーター型に改造したもの等で調節するのが、温度幅が微妙に調節できるので好ましい。なお、シール調製液中のアルコール、例えばエタノールは温度条件によっては揮発することがあるので、シール調製液の成分組成が一定するように適宜、補充するのがよい。 緘 At the time of encapsulation, the band seal preparation liquid can be generally used at room temperature or under heating. From the viewpoint of preventing liquid leakage of the hard capsule, it is desirable to use a seal preparation liquid preferably within a temperature range of about 23 to 45 ° C, more preferably about 23 to 35 ° C, and most preferably about 25 to 35 ° C. The temperature adjustment of the seal preparation liquid can be carried out by a method known per se such as a panel heater and a hot water heater. For example, a circulating hot water heater or a seal pan unit of the integrated capsule filling and sealing machine is circulated. It is preferable to adjust with a hot water heater type modified because the temperature range can be finely adjusted. In addition, since alcohol, for example, ethanol in the seal preparation liquid may volatilize depending on temperature conditions, it is preferable to appropriately replenish the component composition of the seal preparation liquid.
 斯くして得られる本発明の硬質カプセル剤は、内部にPEG,特に平均分子量が200~600の低分子量PEGを充填してもこれらが滲み出すようなことがなく、稼働性に優れているといった利点を備えている。また、かかる低分子量PEGのグリセリン脂肪酸エステルや中鎖脂肪酸トリグリセライドを充填しても皮膜が脆弱化することがないので、これらの低分子量PEGやそのグリセリン脂肪酸エステル及び中鎖脂肪酸トリグリセライドを賦形剤として含む薬剤などにも良好に適用することができる。また、皮膜中の水分低下によっても良好な強度を維持し得、割れ等の不都合を生じることがないので、吸水性を有する薬剤や低水分下での保存が推奨される薬剤にも好適に使用され、更に、水蒸気や酸素がほとんど透過することがないので、水反応性物質や被酸化性物質にも好ましく用いられる。 The thus obtained hard capsule of the present invention is excellent in operability without leaching even when PEG, particularly low molecular weight PEG having an average molecular weight of 200 to 600 is filled therein. Has advantages. In addition, since the film does not become brittle even when glycerin fatty acid ester or medium chain fatty acid triglyceride of low molecular weight PEG is filled, these low molecular weight PEG, its glycerin fatty acid ester and medium chain fatty acid triglyceride are used as excipients. It can be applied well to drugs that contain it. In addition, good strength can be maintained even when the water content in the film is reduced, and there is no inconvenience such as cracking. Therefore, it is also suitable for use in drugs that have water absorption or recommended to be stored under low moisture. Furthermore, since water vapor and oxygen hardly permeate, it is preferably used for water-reactive substances and oxidizable substances.
 III.カプセルフィルムの破断伸び向上方法
 本発明は、PVA共重合体を含有するカプセルフィルム(皮膜)について、破断伸びを向上させる方法を提供する。
III. Method for improving elongation at break of capsule film The present invention provides a method for improving the elongation at break for a capsule film (film) containing a PVA copolymer.
 当該方法は、カプセルフィルム(皮膜)の成分として、PVA共重合体とPVAとを併用することによって、またPVA共重合体と、PVA、ならびに有機酸およびその塩から選択される少なくとも1種とを併用することによって実施することができる。 In this method, as a component of a capsule film (film), a PVA copolymer and PVA are used in combination, and at least one selected from PVA copolymer, PVA, and an organic acid and a salt thereof. It can carry out by using together.
 ここで用いるPVAおよびPVA共重合体の種類は、上記Iで説明したものを同様に挙げることができる。ここでPVAとPVA共重合体の割合は特に制限されないが、通常PVA共重合体:PVA=100:1~1:100(重量比、以下同じ)、好ましくは99:1~1:99である。より好ましくは90:10~1:100(なかでも好ましくは90:10~1:99)、さらに好ましくは80~20:1:100(なかでも好ましくは80:20~1:99)であり、よりさらに好ましくは50:50~1:100(なかでも好ましくは50:50~1:99)、特に好ましくは40:60~1:100(なかでも好ましくは40:60~1:99)である。 As the types of PVA and PVA copolymer used here, those described in I above can be cited. Here, the ratio of the PVA and the PVA copolymer is not particularly limited, but is usually PVA copolymer: PVA = 100: 1 to 1: 100 (weight ratio, the same applies hereinafter), preferably 99: 1 to 1:99. . More preferably, it is 90:10 to 1: 100 (particularly preferably 90:10 to 1:99), still more preferably 80 to 20: 1: 100 (particularly preferably 80:20 to 1:99), More preferably, it is 50:50 to 1: 100 (particularly preferably 50:50 to 1:99), particularly preferably 40:60 to 1: 100 (particularly preferably 40:60 to 1:99). .
 また、これらと併用する有機酸および/またはその塩の種類もIで説明したものを同様に挙げることができる。ここでPVAおよびPVA共重合体と併用する有機酸および/またはその塩の割合は特に制限されない。好ましくは、PVAおよびPVA共重合体ならびに有機酸および/またはその塩の総量100重量%中に含まれる有機酸および/またはその塩(総量)の割合が、有機酸の量に換算して、0.1~19重量%、好ましくは0.15~8重量%、より好ましくは0.2~3重量%、特に好ましくは0.5~1重量%となるような割合をあげることができる。 Also, the types of organic acids and / or their salts used in combination therewith can be the same as those described in I. Here, the ratio of the organic acid and / or salt thereof used in combination with PVA and the PVA copolymer is not particularly limited. Preferably, the ratio of the organic acid and / or salt (total amount) contained in 100% by weight of the total amount of the PVA and PVA copolymer and organic acid and / or salt thereof is 0 in terms of the amount of organic acid. The ratio can be raised to 0.1 to 19% by weight, preferably 0.15 to 8% by weight, more preferably 0.2 to 3% by weight, and particularly preferably 0.5 to 1% by weight.
 当該カプセルフィルムには、Iで説明するように、PVA共重合体およびPVAに加えて(または、PVA共重合体、PVA、ならびに有機酸および/またはその塩に加えて)、ゲル化剤を配合することもでき、さらに必要に応じてゲル化補助剤を配合することもできる。それらの種類および配合割合も、上記Iで説明したものを同様に挙げることができる。 In addition to PVA copolymer and PVA (or in addition to PVA copolymer, PVA, and organic acid and / or salt thereof), the capsule film contains a gelling agent as described in I. It is also possible to add a gelling aid as necessary. Those types and blending ratios can also be the same as those described in I above.
 また、カプセルフィルムには、本発明の効果を妨げない範囲で、上記成分(PVA共重合体とPVA、またはPVA共重合体とPVAと有機酸および/またはその塩、必要に応じてゲル化剤やゲル化補助剤)に加えて、さらに必要に応じて、可塑剤、金属封鎖剤、不透明化剤、着色料または香料などを配合することもできる。 In addition, the above components (PVA copolymer and PVA, or PVA copolymer and PVA and organic acid and / or salt thereof, and a gelling agent as needed) may be included in the capsule film as long as the effects of the present invention are not impaired. And a gelling aid), if necessary, a plasticizer, a metal sequestering agent, an opacifying agent, a coloring agent or a fragrance can be blended.
 本発明の破断伸び向上方法を施すことによって得られる硬質カプセルは、PVAを用いないで調製される硬質カプセル(PVAを使用しない以外は同じ処方と製法で調製された硬質カプセル、以下「対照カプセル」ともいう)に比して破断伸びが大きいため、低水分下でも、ひびや割れなどが生じにくく、耐ひび割れ性および耐衝撃性に優れている。前述するように、硬質カプセルとして、通常5mm~20mmの範囲の破断伸びが要求されるが、かかる破断伸びは、最大応力が70~130Nの範囲で、大きければ大きいほど望ましい。 Hard capsules obtained by applying the method for improving elongation at break of the present invention are hard capsules prepared without using PVA (hard capsules prepared by the same formulation and manufacturing method except that PVA is not used, hereinafter referred to as “control capsule”. Since the elongation at break is larger than that of the other), cracks and cracks are less likely to occur even under low moisture, and it is excellent in crack resistance and impact resistance. As described above, the hard capsule is usually required to have a breaking elongation in the range of 5 mm to 20 mm. The breaking elongation is preferably as large as possible with the maximum stress in the range of 70 to 130 N.
 本発明の方法によれば、最大応力を上記の範囲に維持しながら、対照カプセルより高い破断伸びを実現することができる。好ましい破断伸びは8~20mm、より好ましくは8.5~20mm、さらに好ましくは9~20mmであり、よりさらに好ましくは9.5~20mmである。 According to the method of the present invention, it is possible to achieve higher elongation at break than the control capsule while maintaining the maximum stress in the above range. The breaking elongation is preferably 8 to 20 mm, more preferably 8.5 to 20 mm, still more preferably 9 to 20 mm, and still more preferably 9.5 to 20 mm.
 なお、上記において「低水分下」とは、カプセルフィルムの水分量(%)が、通常5%以下、好ましくは3~5%、より好ましくは3~4%の範囲にあることをいう。カプセルフィルムの水分量(%)は、実験例2(2)に記載する方法に従って測定することができる。 In the above, “under low moisture” means that the moisture content (%) of the capsule film is usually 5% or less, preferably 3 to 5%, more preferably 3 to 4%. The moisture content (%) of the capsule film can be measured according to the method described in Experimental Example 2 (2).
 以下、実験例および実施例を示して本発明を説明するが、本発明はかかる実施例などによって制限されるものではない。なお、特に言及しない限り、下記でいう「%」は重量%を意味する。 Hereinafter, the present invention will be described with reference to experimental examples and examples, but the present invention is not limited to such examples. Unless otherwise specified, “%” in the following means weight%.
 実験例1  最大応力と破断伸びの測定
 ポリビニルアルコール共重合体(以下、「PVA共重合体」という)(POVACOAT Type L:大同化成社製、5%水溶液の25℃における粘度20mPa・s)7.2%、ポリビニルアルコール(以下、「PVA」という)(部分けん化型PVA、重合度1,000、けん化度86~90mol%、和光純薬工業社製)10.8%、カッパカラギーナン(ゲル化剤)0.144%、および塩化カリウム(ゲル化補助剤)0.072%を含有するカプセル調製液を調製し、これをガラス板にフィルム作成用アプリケーターを用いて、乾燥厚が0.1mmとなるように、キャスティングした。これを60℃で2時間乾燥後、23℃、相対湿度40%の環境下で1週間保存したのち、長さ70mm、幅10mmの大きさのフィルムに裁断し、試験フィルムとした。
Experimental Example 1 Measurement of Maximum Stress and Breaking Elongation Polyvinyl alcohol copolymer (hereinafter referred to as “PVA copolymer”) (POVACOAT Type L: manufactured by Daido Kasei Co., Ltd., 5% aqueous solution viscosity at 25 ° C. 20 mPa · s) 2%, polyvinyl alcohol (hereinafter referred to as “PVA”) (partially saponified PVA, polymerization degree 1,000, saponification degree 86-90 mol%, manufactured by Wako Pure Chemical Industries, Ltd.) 10.8%, kappa carrageenan (gelling agent) 0 A capsule preparation solution containing 144% and potassium chloride (gelling aid) 0.072% was prepared, and this was applied to a glass plate using a film making applicator so that the dry thickness was 0.1 mm. Casting. This was dried at 60 ° C. for 2 hours and stored for one week in an environment of 23 ° C. and relative humidity of 40%, and then cut into a film having a length of 70 mm and a width of 10 mm to obtain a test film.
 引張試験は、オートグラフAGS-J(島津製作所製)を用いて、引張速度150mm/min、チャック間距離20mm、引張距離20mm、23℃、相対湿度40%の環境下で測定し、各試験フィルムの最大応力(N)と破断伸び(mm)を測定した。図1に、この引張試験で得られた応力-ひずみ曲線を示す。かくして得られる応力(N)の最大値が、本発明でいう「最大応力」に相当し、また当該最大応力の1/3における引張ストローク(引張距離)が、本発明でいう「破断伸び」に相当する。ここで引張距離20mmにおける応力が最大応力の1/3以上の場合、破断伸びを20mmとした。 The tensile test was performed using an autograph AGS-J (manufactured by Shimadzu Corporation) in an environment where the tensile speed was 150 mm / min, the distance between chucks was 20 mm, the tensile distance was 20 mm, 23 ° C., and the relative humidity was 40%. The maximum stress (N) and elongation at break (mm) were measured. FIG. 1 shows a stress-strain curve obtained in this tensile test. The maximum value of the stress (N) thus obtained corresponds to the “maximum stress” in the present invention, and the tensile stroke (tensile distance) at 1/3 of the maximum stress corresponds to the “breaking elongation” in the present invention. Equivalent to. Here, when the stress at a tensile distance of 20 mm was 1/3 or more of the maximum stress, the elongation at break was 20 mm.
 実験例2  カプセルフィルムの調製
 PVA共重合体、PVA、および有機酸塩の割合が、表2に記載する割合になるように調製したカプセルフィルムを作成した。具体的には、まず、表1に記載する処方に従って52℃のカプセル調製液を調製した。次いで、このカプセル調製液をガラス板にフィルム作成用アプリケーターを用いて、乾燥厚が0.1mmになるようにキャスティングした。60℃で2時間乾燥後、23℃、相対湿度40%の環境下で1週間保存したのち、長さ70mm、幅10mmの大きさのフィルムに裁断し、カプセルフィルム(試料番号1~22)を調製した。
Experimental Example 2 Preparation of Capsule Film A capsule film was prepared so that the ratios of PVA copolymer, PVA, and organic acid salt were in the ratios shown in Table 2. Specifically, first, a capsule preparation solution at 52 ° C. was prepared according to the formulation described in Table 1. Next, this capsule preparation solution was cast on a glass plate using a film-forming applicator so that the dry thickness was 0.1 mm. After drying at 60 ° C for 2 hours and storing for 1 week in an environment of 23 ° C and relative humidity of 40%, it is cut into a film with a length of 70 mm and a width of 10 mm, and a capsule film (sample numbers 1 to 22) Prepared.
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000005
 カプセル調製液の52℃における粘度(mPa・s)、ならびに作成したカプセルフィルムの水分量(%)、最大応力(N)および破断伸び(mm)を下記の方法に従って測定した。 The viscosity (mPa · s) at 52 ° C. of the capsule preparation liquid, the water content (%), the maximum stress (N), and the elongation at break (mm) of the prepared capsule film were measured according to the following methods.
 (1)カプセル調製液(52℃)の粘度(mPa・s)
 粘度は、B型回転粘度計(ローター番号3)を用いて、52℃、回転数12rpm、測定時間1分の条件で測定した。
(1) Viscosity (mPa · s) of capsule preparation liquid (52 ° C)
The viscosity was measured using a B-type rotational viscometer (rotor number 3) under the conditions of 52 ° C., a rotation speed of 12 rpm, and a measurement time of 1 minute.
 (2)カプセルフィルムの水分量(%)
 上記で調製した各カプセルフィルムを23℃、相対湿度40%の環境下で1週間保存したものについて、カプセル水分(%)を求めた。具体的には、まずカプセルフィルムの重量(湿重量)を測定した後、105℃で2時間加熱乾燥し、再度各カプセルフィルムの重量(乾燥重量)を測定した。次いで、乾燥前の重量(湿重量)と乾燥後の重量(乾燥重量)の差から、下式に従って、105℃で2時間加熱乾燥することによって減少する水分量の割合(カプセルフィルム水分量%)を算出した。
(2) Moisture content of capsule film (%)
Each capsule film prepared above was stored for 1 week in an environment of 23 ° C. and a relative humidity of 40%, and the capsule moisture (%) was determined. Specifically, first, the weight (wet weight) of the capsule film was measured and then dried by heating at 105 ° C. for 2 hours, and the weight (dry weight) of each capsule film was measured again. Next, the ratio of moisture content (capsule film moisture content%) that decreases by heating and drying at 105 ° C. for 2 hours according to the following formula from the difference between the weight before drying (wet weight) and the weight after drying (dry weight) Was calculated.
Figure JPOXMLDOC01-appb-M000006
Figure JPOXMLDOC01-appb-M000006
 (3)カプセルフィルムの最大応力および破断伸び
 上記で調製した各カプセルフィルム(試料1~22)について、実験例1の方法に従って、引張試験を実施した。測定した各フィルムの応力と引張ストロークから、実験例1に記載するように最大応力(N)と破断伸び(mm)を求めた。
(3) Maximum Stress and Breaking Elongation of Capsule Film Each capsule film (samples 1 to 22) prepared above was subjected to a tensile test according to the method of Experimental Example 1. From the measured stress and tensile stroke of each film, the maximum stress (N) and elongation at break (mm) were determined as described in Experimental Example 1.
 各測定結果を、各カプセルフィルムのPVA、PVA共重合体および有機酸塩の割合(これらの成分の総量を100重量%として換算)とともに、表2に示す。ここで、換算有機酸%とは、添加した有機酸塩の量を有機酸の量に換算し、全体量に対する百分率としたものである。 Each measurement result is shown in Table 2 together with the ratio of PVA, PVA copolymer and organic acid salt of each capsule film (converted with the total amount of these components as 100% by weight). Here, the converted organic acid% means the amount of the added organic acid salt is converted into the amount of the organic acid and made a percentage with respect to the total amount.
 また試料1~12のカプセルフィルムについて、応力(N)と引張ストローク(mm)を測定した結果を図2に示す。またPVAを含まない試料1の応力(N)と引張ストローク(mm)の測定結果と、PVAを含む試料2~12の当該測定結果とを各々対比した図を、図3~13に示す。 The results of measuring the stress (N) and the tensile stroke (mm) for the capsule films of Samples 1 to 12 are shown in FIG. FIGS. 3 to 13 show the comparison results of the measurement results of the stress (N) and the tensile stroke (mm) of the sample 1 not containing PVA and the measurement results of the samples 2 to 12 containing PVA, respectively.
Figure JPOXMLDOC01-appb-T000007
Figure JPOXMLDOC01-appb-T000007
 この結果から、フィルム成分として、PVA共重合体とPVAとを組み合わせて使用することによって、PVAを併用しないで調製されたカプセルフィルムに比して、有意に破断伸びが向上し、またカプセル調製液の粘度も低下することがわかる。またフィルム成分として、これにさらに有機酸塩を組み合わせて使用することによって、さらに顕著に破断伸びが向上することが判明した。 From this result, as a film component, by using a combination of a PVA copolymer and PVA, the elongation at break is significantly improved as compared with a capsule film prepared without using PVA together, and a capsule preparation solution It can be seen that the viscosity of this also decreases. Further, it was found that the elongation at break is further remarkably improved by further using an organic acid salt in combination with the film component.
 最大応力はいずれも、カプセルとして要求される所定の範囲(70-130N)にあることから、PVA共重合体に、PVAまたはPVAと有機酸塩を組み合わせることにより、水分量が5%以下の低水分条件下でも、衝撃に強く、ひび割れしにくい硬質カプセルが調製できるものと考えられる。 Since the maximum stress is within the predetermined range required for capsules (70-130N), the PVA copolymer can be combined with PVA or PVA and an organic acid salt to reduce the moisture content to 5% or less. It is considered that a hard capsule that is resistant to impact and hard to crack even under moisture conditions can be prepared.
 実験例3  粘度と生産収率
 カプセル調製液の粘度とカプセルの生産収率との関係を調べた。具体的には、PVA共重合体、PVA、ゲル化剤(カラギーナン)、ゲル化補助剤(塩化カリウム)、ゼラチン、HPMCおよび水などを用いて、カプセル調製液の粘度(52℃、B型回転粘度計、ローター番号3、回転数12rpm、測定時間1分)を500、1350、2000、3100および4000mPa・sに調整し、これらの各カプセル調製液でカプセルを作成した場合のカプセル生産収率を求めた。
Experimental Example 3 Viscosity and Production Yield The relationship between the viscosity of the capsule preparation liquid and the capsule production yield was examined. Specifically, using a PVA copolymer, PVA, gelling agent (carrageenan), gelling aid (potassium chloride), gelatin, HPMC, water, etc., the viscosity of the capsule preparation liquid (52 ° C., B-type rotation) Viscometer, rotor number 3, rotation speed 12 rpm, measuring time 1 minute) adjusted to 500, 1350, 2000, 3100 and 4000 mPa · s, and capsule production yield when capsules are made with each of these capsule preparation solutions Asked.
 (1)カプセル生産収率の算出
 カプセルの生産収率(%)は、作成した硬質カプセルについて、カプセル皮膜中の泡やカプセルの変形などの外観上の不良品を選別する外観検査機で良品と判断された単位時間当たりのカプセル数(外観検査後の良品数)と単位時間当たりの理論カプセル製造数(理論カプセル製造数)から下式に従って算出した。
(1) Calculation of capsule production yield Capsule production yield (%) is determined by a visual inspection machine that sorts out defective products such as bubbles in capsule film and deformation of capsules for hard capsules that have been created. The number of capsules per unit time (number of non-defective products after visual inspection) and the number of theoretical capsules manufactured per unit time (the number of theoretical capsules manufactured) were calculated according to the following formula.
Figure JPOXMLDOC01-appb-M000008
Figure JPOXMLDOC01-appb-M000008
 カプセル調製液の粘度(52℃)と生産性(生産収率%)の関係を示す結果を下記表3および図14に示す。 The results showing the relationship between the viscosity (52 ° C.) and the productivity (production yield%) of the capsule preparation liquid are shown in Table 3 below and FIG.
Figure JPOXMLDOC01-appb-T000009
Figure JPOXMLDOC01-appb-T000009
 この結果からわかるように、カプセル調製液の粘度(52℃)を、約3100mPa・s以下にすることで生産収率が5割を超え、さらに約2000mPa・s以下にすることで生産収率が8割を超えるようになり、とりわけ約1500mPa・s以下、特に1350 mPa・s以下とすることにより生産収率が90%を超えるようになる(図14および表3参照)。 As can be seen from this result, the production yield exceeds 50% by setting the viscosity (52 ° C) of the capsule preparation liquid to about 3100 mPa · s or less, and further to about 2000 mPa · s or less. The production yield exceeds 80%, and in particular, the production yield exceeds 90% by setting it to about 1500 mPa · s or less, particularly 1350 μmPa · s or less (see FIG. 14 and Table 3).
 前述する実験例2の結果に示すように、PVA共重合体とPVAとは90:10(重量比)から徐々にPVAの割合を増すことによって粘度を低減させることができる(PVA共重合体:PVA=90:10(重量比)で粘度3100mPa・s、PVA共重合体:PVA=70:30(重量比)で粘度2000mPa・s、PVA共重合体:PVA=50:50(重量比)で粘度1500mPa・s、PVA共重合体:PVA=40:60(重量比)で粘度1350 mPa・s)。すなわち、PVA共重合体とPVAの配合割合をとくに50:50~1:100とすることでカプセル調製液の粘度を約1500mPa・s以下に、また40:60~1:100とすることでカプセル調製液の粘度を、約1350mPa・s以下に調整することができ、その結果、カプセルの生産収率を90%以上にあげることができる。 As shown in the result of Experimental Example 2 described above, the viscosity of the PVA copolymer and PVA can be reduced by gradually increasing the proportion of PVA from 90:10 (weight ratio) (PVA copolymer: PVA = 90: 10 (weight ratio), viscosity 3100 mPa · s, PVA copolymer: PVA = 70: 30 (weight ratio), viscosity 2000 mPa · s, PVA copolymer: PVA = 50: 50 (weight ratio) Viscosity 1500 mPa · s, PVA copolymer: PVA = 40: 60 (weight ratio) and viscosity 1350 mPa · s). That is, when the blending ratio of the PVA copolymer and PVA is particularly 50:50 to 1: 100, the capsule preparation liquid has a viscosity of about 1500 mPa · s or less and 40:60 to 1: 100. The viscosity of the preparation liquid can be adjusted to about 1350 mPa · s or less, and as a result, the production yield of capsules can be increased to 90% or more.
 実験例4  耐衝撃強度試験
(1)硬質カプセルの調製
 40℃の精製水170LにPVA(部分けん化型PVA、重合度1000、けん化度86~90mol%、和光純薬工業社製)を48kg加えて分散させ、82℃まで加温してPVAを溶解させた。これを60℃まで冷却し22%PVA水溶液を調製した。下記表4に示すカプセル調製液の処方に基づき、あらかじめ60℃に加温した22.9%のPVA共重合体(POVACOAT Type L、5%水溶液の粘度が25℃で20mPa・s、大同化成社製)の水溶液に、10%塩化カリウム水溶液、2%カラギーナン水溶液、22%PVA水溶液および精製水を所定量加えて攪拌し、試料番号23~26のカプセル調製液を調製した。これらの溶液を24時間穏やかに攪拌しながら脱泡した。斯くして調製した水溶液(カプセル調製液)を浸漬液として、浸漬法による慣用のカプセル製造装置に仕込み、浸漬液の温度を50~55℃に保持しながら、常法に従ってサイズ1号の硬質カプセル(キャップ、ボディ)を調製した。
Experimental Example 4 Impact Strength Test (1) Preparation of Hard Capsule 48 kg of PVA (partially saponified PVA, polymerization degree 1000, saponification degree 86-90 mol%, manufactured by Wako Pure Chemical Industries, Ltd.) was added to 170 L of purified water at 40 ° C. The PVA was dissolved by dispersing and heating to 82 ° C. This was cooled to 60 ° C. to prepare a 22% PVA aqueous solution. Based on the formulation of the capsule preparation solution shown in Table 4 below, 22.9% PVA copolymer preheated to 60 ° C (POVACOAT Type L, viscosity of 5% aqueous solution is 20 mPa · s at 25 ° C, Daido Kasei Co., Ltd.) A predetermined amount of 10% potassium chloride aqueous solution, 2% carrageenan aqueous solution, 22% PVA aqueous solution and purified water were added and stirred to prepare a capsule preparation solution of sample numbers 23 to 26. These solutions were degassed with gentle stirring for 24 hours. Using the aqueous solution thus prepared (capsule preparation solution) as an immersion liquid, it was charged in a conventional capsule manufacturing apparatus by the immersion method, and the size 1 hard capsule was maintained according to a conventional method while maintaining the temperature of the immersion liquid at 50 to 55 ° C. (Cap, body) was prepared.
Figure JPOXMLDOC01-appb-T000010
Figure JPOXMLDOC01-appb-T000010
 (2)硬質カプセルの水分量(%)
 上記で調製した各硬質カプセルを23℃、相対湿度12%、22%、33%、43%および53%の環境下で1週間保存したものについて、硬質カプセル水分量(%)を求めた。具体的には、まず上記保存後の硬質カプセルの重量(湿重量)を測定した後、105℃で2時間加熱乾燥し、再度各硬質カプセルの重量(乾燥重量)を測定した。次いで、乾燥前の重量(湿重量)と乾燥後の重量(乾燥重量)の差から、下式に従って、105℃で2時間加熱乾燥することによって減少する水分量の割合(硬質カプセル水分量%)を算出した。
(2) Moisture content of hard capsule (%)
The hard capsule water content (%) was determined for each of the hard capsules prepared above and stored for 1 week in an environment of 23 ° C., 12%, 22%, 33%, 43% and 53% relative humidity. Specifically, first, the weight (wet weight) of the hard capsules after the storage was measured, and then dried by heating at 105 ° C. for 2 hours, and the weight (dry weight) of each hard capsule was measured again. Next, the ratio of the amount of water that decreases by heating and drying at 105 ° C. for 2 hours according to the following formula from the difference between the weight before drying (wet weight) and the weight after drying (dry weight) (hard capsule moisture amount%) Was calculated.
Figure JPOXMLDOC01-appb-M000011
Figure JPOXMLDOC01-appb-M000011
 結果を表5に示す。 The results are shown in Table 5.
Figure JPOXMLDOC01-appb-T000012
Figure JPOXMLDOC01-appb-T000012
 (3)硬質カプセルの割れ率(%)
 上記で調製した各硬質カプセルを23℃、相対湿度12%、22%、33%、43%および53%の環境下で1週間保存したものについて、硬質カプセルの割れ率(%)を求めた。具体的には、上記保存後の各硬質カプセルに対して、50gの錘を高さ10cmから自然落下させ、割れた硬質カプセル数を計数した。割れた硬質カプセル数から下式に従って硬質カプセルの割れ率(%)を算出した。
(3) Hard capsule crack rate (%)
Each hard capsule prepared above was stored for 1 week in an environment of 23 ° C., 12%, 22%, 33%, 43% and 53% relative humidity, and the cracking rate (%) of the hard capsule was determined. Specifically, a 50 g weight was naturally dropped from a height of 10 cm to each hard capsule after the storage, and the number of broken hard capsules was counted. The cracking rate (%) of the hard capsules was calculated from the number of broken hard capsules according to the following formula.
Figure JPOXMLDOC01-appb-M000013
Figure JPOXMLDOC01-appb-M000013
 結果を図15に示す。この結果から、フィルム成分として、PVA共重合体とPVAとを組み合わせて使用することによって(試料番号24~26)、PVAを併用しないで調製されたカプセルフィルム(試料番号23)に比して、割れ耐性や衝撃耐性が向上することがわかる。またPVAを併用することで、併用しない場合と比べて低水分条件下でも、衝撃に強く、ひび割れしにくい硬質カプセルが調製できることが判明した。 The results are shown in FIG. From this result, as a film component, by using a combination of a PVA copolymer and PVA (sample numbers 24-26), compared to a capsule film (sample number 23) prepared without using PVA together, It can be seen that crack resistance and impact resistance are improved. It has also been found that by using PVA in combination, a hard capsule that is resistant to impact and hardly cracks can be prepared even under low moisture conditions as compared with the case where PVA is not used in combination.
 実験例5
 バンドシール原料として、PVA共重合体(大同化成社製のPOVACOAT Type F、5%水溶液の25℃の粘度5.5mPa・s)、PVA((日本酢ビ・ポバール社製のJP-05、平均重合度500、部分けん化型PVA:けん化度87-89mol%)、およびソルビトールを用いて表6の処方からなるバンドシール調製液(処方例1~19)を作成した。なお、表中の括弧内は、乾燥後のバンドシールの重量(乾燥重量)を100重量%とした場合のPVA共重合体、PVAおよびソルビトールの重量比を示す。次いで、各バンドシール調製液(処方例1~19)について、下記の方法に従って、粘度を測定するとともに、液だれ、曳糸性および流動性の点から硬質カプセルに塗布するうえでの取り扱い性を評価した。
Experimental Example 5
PVA copolymer (POVACOAT Type F, manufactured by Daido Kasei Co., Ltd., viscosity of 5.5 mPa · s at 25 ° C, 5% aqueous solution), PVA (JP-05, manufactured by Nihon Vinegar-Poval, average polymerization) A band seal preparation solution (formulation examples 1 to 19) having a formulation shown in Table 6 was prepared using a degree of 500, a partially saponified PVA (degree of saponification: 87-89 mol%), and sorbitol. The weight ratio of the PVA copolymer, PVA and sorbitol when the weight of the band seal after drying (dry weight) is 100% by weight is shown below. According to the following method, the viscosity was measured, and the handleability when applied to a hard capsule was evaluated from the viewpoint of dripping, spinnability and fluidity.
 次いで得られたバンドシール調製液を、全自動カプセル充填・シール機(クオリカプス社製)を用いて実施例1の方法に従って調製した硬質カプセルに、470μLのPEG400を充填するとともに、上記のバンドシール調製液で、硬質カプセルのボディ部とキャップ部の嵌合部を封緘し、硬質カプセル剤を調製した。この封緘硬質カプセル剤の外観を目視観察して漏出物やソルビトールの析出の有無を観察するととともに、下記の方法に従って、温度25℃、相対湿度40%の環境下で、白色コピー用紙の上に12時間放置して、内容物の漏出の有無からバンドシール性を評価した。 Next, the obtained band seal preparation liquid was filled with 470 μL of PEG400 into a hard capsule prepared according to the method of Example 1 using a fully automatic capsule filling and sealing machine (manufactured by Qualicaps Co., Ltd.), and the above band seal preparation was performed. The body part of the hard capsule and the fitting part of the cap part were sealed with a liquid to prepare a hard capsule. The appearance of the sealed hard capsule was visually observed to observe the presence or absence of leakage or sorbitol precipitation, and in accordance with the following method, the temperature was 25 ° C. and the relative humidity was 40%. The band sealability was evaluated from the presence or absence of leakage of the contents after standing for a period of time.
 (1)バンドシール調製液の粘度の測定
 粘度は、B型回転粘度計(粘度500mPa・s未満の場合はローター番号2、粘度500mPa・s以上2000mPa・s未満の場合はローター番号3、粘度2000mPa・s以上の場合はローター番号4)を用いて、23℃、回転数60rpm、測定時間1分の条件で測定した。
(1) Viscosity of the band seal preparation liquid is measured using a B-type rotational viscometer (rotor number 2 when the viscosity is less than 500 mPa · s, rotor number 3 when the viscosity is 500 mPa · s to less than 2000 mPa · s, and viscosity is 2000 mPa In the case of s or more, the measurement was performed using a rotor number 4) under the conditions of 23 ° C., rotation speed 60 rpm, and measurement time 1 minute.
 (2)バンドシール調製液の取り扱い性(液だれの有無、曳糸性および流動性)評価
 各バンドシール調製液について、液だれ、曳糸性および流動性の全ての点から硬質カプセルに塗布する取り扱い条件を満たしている場合を「適正:○」と評価し、一つでも条件を満たしていない場合を「不適正:×」と評価した。
(2) Evaluation of handling property (presence / absence of dripping, spinnability and fluidity) of band seal preparation liquid Each band seal preparation liquid is applied to a hard capsule from all points of dripping, spinnability and fluidity. The case where the handling conditions were satisfied was evaluated as “appropriate: ○”, and the case where even one of the conditions was not satisfied was evaluated as “inappropriate: ×”.
 (3)バンドシール性の評価
 上記で調製した封緘硬質カプセルを、23℃、RH43%の条件で1日間放置して、外観上の変化、特に嵌合部周囲に形成したバンドシールの状態を観察した。
(3) Evaluation of band sealing properties The sealed hard capsules prepared above were allowed to stand for 1 day at 23 ° C. and RH 43% to observe changes in appearance, particularly the state of the band seal formed around the fitting part. did.
 またさらに各封緘硬質カプセル剤を、温度25℃、相対湿度40%の環境下で、白色コピー用紙の上に12時間放置した。12時間後、バンドシール部からの内容物(PEG400)の漏出の有無を、下記の方法および基準により確認した。 Further, each sealed hard capsule was left on a white copy paper for 12 hours in an environment of a temperature of 25 ° C. and a relative humidity of 40%. After 12 hours, the presence or absence of leakage of the contents (PEG400) from the band seal part was confirmed by the following method and criteria.
 (a) 12時間放置後、封緘硬質カプセル剤と接していた白色コピー用紙面に、内容物(PEG400)が付着しているか否か。
(b) 12時間放置後、封緘硬質カプセル剤を白色コピー用紙上で転がしたときに、白色コピー用紙面に内容物(PEG400)が付着するか否か。
(a) Whether the content (PEG400) is attached to the surface of the white copy paper that has been in contact with the sealed hard capsule after standing for 12 hours.
(b) Whether the contents (PEG400) adhere to the surface of the white copy paper when the sealed hard capsule is rolled on the white copy paper after being left for 12 hours.
 (a)と(b)のいずれの場合も、白色コピー用紙への内容物の付着、すなわち内容物の漏出が認められない場合を「バンドシール性あり:○」、(a)と(b)のいずれかの場合で内容物の漏出が認められる場合を「バンドシール性なし:×」と判定する。 In both cases (a) and (b), when there is no adhesion of the contents to the white copy paper, that is, no leakage of the contents is recognized, “band sealability: ○”, (a) and (b) In any of the cases, the case where leakage of the contents is recognized is determined as “no band sealability: x”.
 結果を表6に併せて示す。 The results are also shown in Table 6.
Figure JPOXMLDOC01-appb-T000014
Figure JPOXMLDOC01-appb-T000014
 以上の結果から、PVAおよびPVA共重合体は、単独またはその混合物としてバンドシール原料として好適に使用することができること、さらにこれにソルビトールを70重量%以下の割合で配合した場合も、バンドシールとして好適に使用できることがわかった。なお、ソルビトールの配合割合は、バンドシール性という点からは70重量%以下であれば特に問題はないものの、ソルビトールの析出という点からは40重量%未満、好ましくは35重量%以下、より好ましくは30重量%以下であることが好ましい。 From the above results, the PVA and PVA copolymer can be suitably used as a band seal raw material alone or as a mixture thereof, and even when sorbitol is blended in a proportion of 70% by weight or less, It turned out that it can be used conveniently. The blending ratio of sorbitol is not particularly problematic if it is 70% by weight or less from the viewpoint of band sealability, but less than 40% by weight, preferably 35% by weight or less, more preferably from the point of precipitation of sorbitol. It is preferable that it is 30 weight% or less.
 実施例1  硬質カプセル剤の調製
(1)硬質カプセルの調製
 40℃の精製水170LにPVA(部分けん化型PVA、重合度は1000、けん化度86~90mol%、和光純薬工業社製)を48kg加えて分散させ、82℃まで加温してPVAを溶解させた。これを60℃まで冷却しPVA水溶液を調製した。あらかじめ60℃に加温した22.9%のPVA共重合体(POVACOAT Type L、5%水溶液の粘度が25℃で20mPa・s、大同化成社製)の水溶液34.93kgに、10%塩化カリウム水溶液0.8kg、2%カラギーナン水溶液8kg、PVA水溶液54.55kgおよび精製水1.72kgを加えて攪拌した。この溶液を24時間穏やかに攪拌しながら脱泡した。斯くして調製した水溶液(カプセル調製液)を浸漬液として、浸漬法による慣用のカプセル製造装置に仕込み、浸漬液の温度を50~55℃に保持しながら、常法に従ってサイズ1号または2号の硬質カプセル(キャップ、ボディ)を調製した。
Example 1 Preparation of hard capsule (1) Preparation of hard capsule 48 kg of PVA (partially saponified PVA, polymerization degree 1000, saponification degree 86-90 mol%, manufactured by Wako Pure Chemical Industries, Ltd.) in 170 L of purified water at 40 ° C. In addition, the mixture was dispersed and heated to 82 ° C. to dissolve the PVA. This was cooled to 60 ° C. to prepare an aqueous PVA solution. 10% potassium chloride was added to 34.93 kg of an aqueous solution of 22.9% PVA copolymer (POVACOAT Type L, 5% aqueous solution viscosity at 25 ° C, 20 mPa · s, manufactured by Daido Kasei Co., Ltd.) preheated to 60 ° C. 0.8 kg of aqueous solution, 8 kg of 2% carrageenan aqueous solution, 54.55 kg of PVA aqueous solution and 1.72 kg of purified water were added and stirred. The solution was degassed with gentle stirring for 24 hours. The aqueous solution thus prepared (capsule preparation solution) was used as an immersion liquid and charged into a conventional capsule manufacturing apparatus by an immersion method, and the size No. 1 or No. 2 was maintained according to a conventional method while maintaining the temperature of the immersion liquid at 50 to 55 ° C. Hard capsules (caps, bodies) were prepared.
 (2)内容物(PEG400)の充填
 全自動カプセル充填機(クオリカプス社製、LIQFILsuper40)を用いて、上記で調製したサイズ1号の硬質カプセルに、平均分子量400のポリエチレングリコール(PEG400)を470μL充填した。次いで、全自動カプセル充填・シール機(クオリカプス社製、LIQFILsuperFS)を用いて、上記でPEG400を充填した硬質カプセルのキャップとボディの嵌合部に、下記の処方からなるバンドシール液を塗布し、乾燥させて、内部にPEG400を充填してなる本発明の硬質カプセル剤を調製した。
(2) Filling of contents (PEG400) Using a fully automatic capsule filling machine (LIQFILsuper40, manufactured by Qualicaps Co., Ltd.), 470 μL of polyethylene glycol (PEG400) having an average molecular weight of 400 is filled in the size 1 hard capsule prepared above. did. Next, using a fully automatic capsule filling and sealing machine (Qualicaps, LIQFILsuperFS), a band seal solution composed of the following formulation is applied to the cap and body fitting portion of the hard capsule filled with PEG400 as described above. The hard capsule of the present invention was prepared by drying and filling PEG400 inside.
実験例1の引張試験で得られた応力-ひずみ曲線を示す。2 shows a stress-strain curve obtained in the tensile test of Experimental Example 1. 実験例2の引張試験において、試料番号1~12のカプセルフィルムについて応力(N)と引張ストローク(mm)を測定した結果を示す。In the tensile test of Experimental Example 2, the results of measuring the stress (N) and the tensile stroke (mm) for the capsule films of sample numbers 1 to 12 are shown. 実験例2の引張試験において、試料番号1と試料番号2のカプセルフィルムについて、応力(N)と引張ストローク(mm)を対比した結果を示す。In the tensile test of Experimental Example 2, the results of comparing the stress (N) and the tensile stroke (mm) for the capsule films of Sample No. 1 and Sample No. 2 are shown. 実験例2の引張試験において、試料番号1と試料番号3のカプセルフィルムについて、応力(N)と引張ストローク(mm)を対比した結果を示す。In the tensile test of Experimental Example 2, the results of comparing the stress (N) and the tensile stroke (mm) for the capsule films of Sample No. 1 and Sample No. 3 are shown. 実験例2の引張試験において、試料番号1と試料番号4のカプセルフィルムについて、応力(N)と引張ストローク(mm)を対比した結果を示す。In the tensile test of Experimental Example 2, the results of comparing the stress (N) and the tensile stroke (mm) for the capsule films of Sample No. 1 and Sample No. 4 are shown. 実験例2の引張試験において、試料番号1と試料番号5のカプセルフィルムについて、応力(N)と引張ストローク(mm)を対比した結果を示す。In the tensile test of Experimental Example 2, the results of comparing the stress (N) and the tensile stroke (mm) for the capsule films of Sample No. 1 and Sample No. 5 are shown. 実験例2の引張試験において、試料番号1と試料番号6のカプセルフィルムについて、応力(N)と引張ストローク(mm)を対比した結果を示す。In the tensile test of Experimental Example 2, the results of comparing the stress (N) and the tensile stroke (mm) for the capsule films of Sample No. 1 and Sample No. 6 are shown. 実験例2の引張試験において、試料番号1と試料番号7のカプセルフィルムについて、応力(N)と引張ストローク(mm)を対比した結果を示す。In the tensile test of Experimental Example 2, the results of comparing the stress (N) and the tensile stroke (mm) for the capsule films of Sample No. 1 and Sample No. 7 are shown. 実験例2の引張試験において、試料番号1と試料番号8のカプセルフィルムについて、応力(N)と引張ストローク(mm)を対比した結果を示す。In the tensile test of Experimental Example 2, the results of comparing the stress (N) and the tensile stroke (mm) for the capsule films of Sample No. 1 and Sample No. 8 are shown. 実験例2の引張試験において、試料番号1と試料番号9のカプセルフィルムについて、応力(N)と引張ストローク(mm)を対比した結果を示す。In the tensile test of Experimental Example 2, the results of comparing the stress (N) and the tensile stroke (mm) for the capsule films of Sample No. 1 and Sample No. 9 are shown. 実験例2の引張試験において、試料番号1と試料番号10のカプセルフィルムについて、応力(N)と引張ストローク(mm)を対比した結果を示す。In the tensile test of Experimental Example 2, the results of comparing the stress (N) and the tensile stroke (mm) for the capsule films of Sample No. 1 and Sample No. 10 are shown. 実験例2の引張試験において、試料番号1と試料番号11のカプセルフィルムについて、応力(N)と引張ストローク(mm)を対比した結果を示す。In the tensile test of Experimental Example 2, the results of comparing the stress (N) and the tensile stroke (mm) for the capsule films of Sample No. 1 and Sample No. 11 are shown. 実験例2の引張試験において、試料番号1と試料番号12のカプセルフィルムについて、応力(N)と引張ストローク(mm)を対比した結果を示す。In the tensile test of Experimental Example 2, the results of comparing the stress (N) and the tensile stroke (mm) for the capsule films of Sample No. 1 and Sample No. 12 are shown. 実験例3において、カプセル調製液の粘度と硬質カプセルの生産収率%との相関関係を調べた結果を示すグラフである。In Experimental Example 3, it is a graph which shows the result of having investigated the correlation of the viscosity of a capsule preparation liquid, and the production yield% of a hard capsule. 実験例4において、各種硬質カプセル(試料番号23~26)について、各相対湿度(%)における割れ率(%)を評価した結果を示す。In Experimental Example 4, the results of evaluating the cracking rate (%) at various relative humidity (%) for various hard capsules (sample numbers 23 to 26) are shown.

Claims (17)

  1.  ポリビニルアルコール共重合体およびポリビニルアルコールを含有するフィルムからなる硬質カプセル。 Hard capsule made of a film containing polyvinyl alcohol copolymer and polyvinyl alcohol.
  2.  フィルムに含まれるポリビニルアルコール共重合体とポリビニルアルコールとの重量比が99:1~1:99である、請求項1に記載する硬質カプセル。 The hard capsule according to claim 1, wherein the weight ratio of the polyvinyl alcohol copolymer and the polyvinyl alcohol contained in the film is 99: 1 to 1:99.
  3.  フィルムに含まれるポリビニルアルコール共重合体とポリビニルアルコールとの重量比が50:50~1:99である、請求項1に記載する硬質カプセル。 The hard capsule according to claim 1, wherein the weight ratio of the polyvinyl alcohol copolymer and the polyvinyl alcohol contained in the film is 50:50 to 1:99.
  4.  さらに、ゲル化剤を含有する請求項1に記載する硬質カプセル。 The hard capsule according to claim 1, further comprising a gelling agent.
  5.  さらに、ゲル化補助剤を含有する請求項4に記載する硬質カプセル。 Further, the hard capsule according to claim 4, further comprising a gelling aid.
  6.  フィルムの水分量が3~5%であり、破断伸びが5~20mmであることを特徴とする請求項1に記載する硬質カプセル。 2. The hard capsule according to claim 1, wherein the moisture content of the film is 3 to 5% and the elongation at break is 5 to 20 mm.
  7.  請求項1乃至6のいずれかに記載する硬質カプセルに、ポリエチレングリコールまたはポリエチレングリコールを含む組成物が充填されてなる、硬質カプセル剤。 A hard capsule obtained by filling the hard capsule according to any one of claims 1 to 6 with a composition containing polyethylene glycol or polyethylene glycol.
  8.  上記ポリエチレングリコールが、平均分子量200~600の低分子量ポリエチレングリコールである、請求項7記載の硬質カプセル剤。 The hard capsule according to claim 7, wherein the polyethylene glycol is a low molecular weight polyethylene glycol having an average molecular weight of 200 to 600.
  9.  ボディ部とキャップ部の嵌合部が、ポリビニルアルコール共重合体、ポリビニルアルコールまたはこれらの混合物を含有するバンドシールで封緘されてなることを特徴とする、請求項7に記載する硬質カプセル剤。 The hard capsule according to claim 7, wherein the fitting part between the body part and the cap part is sealed with a band seal containing a polyvinyl alcohol copolymer, polyvinyl alcohol or a mixture thereof.
  10.  バンドシールが更に可塑剤としてソルビトールを含有するものである、請求項8に記載する硬質カプセル剤。 The hard capsule according to claim 8, wherein the band seal further contains sorbitol as a plasticizer.
  11.  ポリビニルアルコール共重合体およびポリビニルアルコールを含有するカプセル調製液に、カプセル成型用ピンを浸漬して引き上げ、当該成型用ピンに付着した上記カプセル調製液をゲル化、乾燥させ、これを成型ピンから脱離回収して硬質カプセルを得ることを特徴とする、請求項1乃至6のいずれかに記載する硬質カプセルの製造方法。 Capsule molding pins are dipped in a capsule preparation solution containing polyvinyl alcohol copolymer and polyvinyl alcohol and pulled up, the capsule preparation solution adhering to the molding pins is gelled and dried, and this is removed from the molding pins. The method for producing a hard capsule according to any one of claims 1 to 6, wherein the hard capsule is obtained by separation and collection.
  12.  請求項1乃至6のいずれかに記載する硬質カプセル内に内容物を充填した後、キャップ部とボディ部を嵌合し、形成された嵌合部に、ポリビニルアルコール共重合体、ポリビニルアルコールまたはこれらの混合物を含有するバンドシール調製液を塗布し、乾燥して封緘することを特徴とする硬質カプセル剤の調製方法。 After filling the hard capsule according to any one of claims 1 to 6, the cap portion and the body portion are fitted, and the formed fitting portion has a polyvinyl alcohol copolymer, polyvinyl alcohol, or these. A method for preparing a hard capsule, comprising applying a band seal preparation solution containing a mixture of the above, followed by drying and sealing.
  13.  上記内容物がポリエチレングリコールまたはポリエチレングリコールを含む組成物である、請求項12に記載する硬質カプセル剤の調製方法。 The method for preparing a hard capsule according to claim 12, wherein the content is polyethylene glycol or a composition containing polyethylene glycol.
  14.  ポリビニルアルコール共重合体を含有するカプセルフィルムの破断伸び向上方法であって、カプセルフィルムの成分として、ポリビニルアルコール共重合体とポリビニルアルコールとを併用することを特徴とする方法。 A method for improving the elongation at break of a capsule film containing a polyvinyl alcohol copolymer, wherein a polyvinyl alcohol copolymer and polyvinyl alcohol are used in combination as a component of the capsule film.
  15.  上記カプセルフィルムに配合するポリビニルアルコール共重合体とポリビニルアルコールとの重量比が、99:1~1:99である、請求項14に記載するカプセルフィルムの破断伸び向上方法。 15. The method for improving the elongation at break of a capsule film according to claim 14, wherein the weight ratio of the polyvinyl alcohol copolymer and polyvinyl alcohol to be blended in the capsule film is 99: 1 to 1:99.
  16.  カプセルフィルムの成分として、さらに、有機酸およびその塩からなる群から選択される少なくとも1種を併用することを特徴とする、請求項14に記載するカプセルフィルムの破断伸び向上方法。 15. The capsule film breaking elongation improving method according to claim 14, wherein at least one selected from the group consisting of an organic acid and a salt thereof is further used as a component of the capsule film.
  17.  上記有機酸の塩が、有機酸のアルカリ金属塩である請求項16に記載するカプセルフィルムの破断伸び向上方法。 The method for improving elongation at break of a capsule film according to claim 16, wherein the salt of the organic acid is an alkali metal salt of an organic acid.
PCT/JP2008/057084 2008-04-10 2008-04-10 Hard capsule WO2009125483A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/JP2008/057084 WO2009125483A1 (en) 2008-04-10 2008-04-10 Hard capsule
JP2010507091A JP5289429B2 (en) 2008-04-10 2008-04-10 Hard capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2008/057084 WO2009125483A1 (en) 2008-04-10 2008-04-10 Hard capsule

Publications (1)

Publication Number Publication Date
WO2009125483A1 true WO2009125483A1 (en) 2009-10-15

Family

ID=41161626

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/057084 WO2009125483A1 (en) 2008-04-10 2008-04-10 Hard capsule

Country Status (2)

Country Link
JP (1) JP5289429B2 (en)
WO (1) WO2009125483A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011105534A1 (en) 2010-02-26 2011-09-01 日新化成株式会社 Hard capsule and method for producing same
JP2015017245A (en) * 2013-06-13 2015-01-29 花王株式会社 Detergent composition
WO2018008660A1 (en) 2016-07-06 2018-01-11 クオリカプス株式会社 Hard capsule having improved hardness, and method for manufacturing same
WO2020071395A1 (en) 2018-10-02 2020-04-09 クオリカプス株式会社 Improved-strength hard capsule and production method for same
WO2020071393A1 (en) 2018-10-02 2020-04-09 クオリカプス株式会社 Improved-strength hard capsule and production method for same
KR102157584B1 (en) * 2020-04-15 2020-09-18 (주)한국원자력 엔지니어링 Method of manufacturing pills
WO2021024930A1 (en) 2019-08-02 2021-02-11 クオリカプス株式会社 Hard capsule formulation sealed with band seal including tag

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09216818A (en) * 1995-12-04 1997-08-19 Kyowa Hakko Kogyo Co Ltd Hard capsule
JP2001170137A (en) * 1999-12-16 2001-06-26 Shionogi Qualicaps Kk Hard capsule and method for manufacturing therefor
US20010043999A1 (en) * 1998-03-11 2001-11-22 Scott Robert A. Polyvinyl alcohol compositions
WO2002017848A1 (en) * 2000-08-29 2002-03-07 Nisshin Kasei Co., Ltd. Hard capsule

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09216818A (en) * 1995-12-04 1997-08-19 Kyowa Hakko Kogyo Co Ltd Hard capsule
US20010043999A1 (en) * 1998-03-11 2001-11-22 Scott Robert A. Polyvinyl alcohol compositions
JP2001170137A (en) * 1999-12-16 2001-06-26 Shionogi Qualicaps Kk Hard capsule and method for manufacturing therefor
WO2002017848A1 (en) * 2000-08-29 2002-03-07 Nisshin Kasei Co., Ltd. Hard capsule

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011105534A1 (en) 2010-02-26 2011-09-01 日新化成株式会社 Hard capsule and method for producing same
JPWO2011105534A1 (en) * 2010-02-26 2013-06-20 日新化成株式会社 Hard capsule and method for producing the same
US8900628B2 (en) 2010-02-26 2014-12-02 Nisshin Kasei Co., Ltd. Hard capsule and method for producing same
JP5705206B2 (en) * 2010-02-26 2015-04-22 日新化成株式会社 Hard capsule and method for producing the same
JP2015017245A (en) * 2013-06-13 2015-01-29 花王株式会社 Detergent composition
WO2018008660A1 (en) 2016-07-06 2018-01-11 クオリカプス株式会社 Hard capsule having improved hardness, and method for manufacturing same
US11318101B2 (en) 2016-07-06 2022-05-03 Qualicaps Co., Ltd. Hard capsule having improved hardness, and method for manufacturing same
WO2020071395A1 (en) 2018-10-02 2020-04-09 クオリカプス株式会社 Improved-strength hard capsule and production method for same
WO2020071393A1 (en) 2018-10-02 2020-04-09 クオリカプス株式会社 Improved-strength hard capsule and production method for same
WO2021024930A1 (en) 2019-08-02 2021-02-11 クオリカプス株式会社 Hard capsule formulation sealed with band seal including tag
KR102157584B1 (en) * 2020-04-15 2020-09-18 (주)한국원자력 엔지니어링 Method of manufacturing pills

Also Published As

Publication number Publication date
JP5289429B2 (en) 2013-09-11
JPWO2009125483A1 (en) 2011-07-28

Similar Documents

Publication Publication Date Title
JP5248739B2 (en) Enteric preparation
US9700517B2 (en) Acid resistant capsules
US10525010B2 (en) Aqueous dispersions of controlled release polymers and shells and capsules thereof
JP5289429B2 (en) Hard capsule
JP5253235B2 (en) Enteric capsule
US9925719B2 (en) Bandseal for PEG-filled hard capsule
US11318101B2 (en) Hard capsule having improved hardness, and method for manufacturing same
CN110891552B (en) Enteric hard capsule
US20090010975A1 (en) Non-transparent composition for film
JP2009196961A (en) Enteric capsule
CN110191723B (en) Hard capsules exhibiting improved deposition of gel aid and method for preparing same
JP5328768B2 (en) Hard capsule
JP2022123274A (en) Enteric-coated hard capsule
US20210369627A1 (en) Improved-strength hard capsule and production method for same
JP7472028B2 (en) Hard capsule with improved strength and method for producing same
JP7366893B2 (en) Enteric coated hard capsule

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08740185

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2010507091

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08740185

Country of ref document: EP

Kind code of ref document: A1